Validation pour Ingenuity255

vers la météo de la validation par utilisateur

Ingenuity255

precedent - 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 - suivant

Phrase 74 - PMID ?

In liver from male SP , dietary administration of NODE ( with a dosage of 1 percent and a treatment period of 1 week ) and dietary administration of NODE ( with a dosage of 00.2percent and a treatment period of 1 week ) decrease expression of SP NODE mRNA 1 week after initial treatment .

Non annotée
Je ne sais pas
Je n'ai pas trouvé d'analyse satisfaisante

Commentaires :

Analyse 0

      +------------COMP:N-N(from)-----------+                                                                                                                                                  +----------------------COMP:N-N(of)---------------------+                                                             
      |          +-------MOD_ATT:N-ADJ------+---------------------------COMP:N-N(with)--------------------------+                                                 +---------------------COMP:N-N(of)---------------------+---------COMP:N-N(of)--------+-------COMP:N-N(of)-------+                                  
      |          |     +----MOD_ATT:N-ADJ---+---------COMP:N-N(with)--------+COMP:N-N(of+                       +-----------COMP:N-N(of)-----------+              +--------COMP:N-N(of)--------+                         |          +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+------COMP:N-N(after)------+      
      |          |     |        +MOD_ATT:N-A+-COMP:N-N(of)-+                |      +MOD_+              +MOD_ATT:+COMP:N-N(o+           +MOD_ATT:N-A+-COMP:N-N(of)-+-COMP:N-N(with)-+           |                +MOD_ATT:+          |        +MOD_ATT:N+           |       +MOD_AT+      +MOD:+      +MOD_ATT:+      
      |          |     |        |           |              |                |      |    |              |        |          |           |           |              |                |           |                |        |          |        |         |           |       |      |      |    |      |        |      
 In liver from male __SP__ , dietary administration of __NODE__ ( with a dosage of 1 percent and a treatment period of 1 week ) and dietary administration of __NODE__ ( with a dosage of 00.2percent and a treatment period of 1 week ) decrease expression of __SP__ __NODE__ mRNA 1 week after initial treatment .
COMP:N-N(from) (liver,administration)
MOD_ATT:N-ADJ (administration,male)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-ADJ (administration,dietary)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (administration,dosage)
COMP:N-N(with) (administration,period)
COMP:N-N(of) (dosage,percent)
MOD_ATT:N-ADJ (percent,1)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
COMP:N-N(of) (period,administration)
MOD_ATT:N-ADJ (administration,dietary)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (__NODE__,dosage)
COMP:N-N(of) (__NODE__,00.2percent)
COMP:N-N(of) (__NODE__,period)
COMP:N-N(of) (00.2percent,expression)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,expression)
MOD_ATT:N-N (expression,week)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD:ADV-N (after,week)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 1

      +------------COMP:N-N(from)-----------+                                                                                                                                                  +----------------------COMP:N-N(of)---------------------+                                                             
      |          +-------MOD_ATT:N-ADJ------+                               +------------COMP:N-N(of)-----------+                                                                              |                         +---------COMP:N-N(of)--------+-------COMP:N-N(of)-------+                                  
      |          |     +----MOD_ATT:N-ADJ---+---------COMP:N-N(with)--------+COMP:N-N(of+                       +-----------COMP:N-N(of)-----------+---------COMP:N-N(with)--------+-------------COMP:N-N(of)------------+          +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+------COMP:N-N(after)------+      
      |          |     |        +MOD_ATT:N-A+-COMP:N-N(of)-+                |      +MOD_+              +MOD_ATT:+COMP:N-N(o+           +MOD_ATT:N-A+-COMP:N-N(of)-+                +COMP:N-N(of+                +MOD_ATT:+          |        +MOD_ATT:N+           |       +MOD_AT+      +MOD:+      +MOD_ATT:+      
      |          |     |        |           |              |                |      |    |              |        |          |           |           |              |                |           |                |        |          |        |         |           |       |      |      |    |      |        |      
 In liver from male __SP__ , dietary administration of __NODE__ ( with a dosage of 1 percent and a treatment period of 1 week ) and dietary administration of __NODE__ ( with a dosage of 00.2percent and a treatment period of 1 week ) decrease expression of __SP__ __NODE__ mRNA 1 week after initial treatment .
COMP:N-N(from) (liver,administration)
MOD_ATT:N-ADJ (administration,male)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-ADJ (administration,dietary)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (administration,dosage)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,1)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
COMP:N-N(of) (period,administration)
MOD_ATT:N-ADJ (administration,dietary)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (administration,dosage)
COMP:N-N(of) (dosage,00.2percent)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (00.2percent,expression)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,expression)
MOD_ATT:N-N (expression,week)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD:ADV-N (after,week)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 2

      +------------COMP:N-N(from)-----------+                                                                                                                                                  +----------------------COMP:N-N(of)---------------------+                                                             
      |          +--------MOD_ATT:N-N-------+---------------------------COMP:N-N(with)--------------------------+          +-------------COMP:N-N(of)-------------+---------------------COMP:N-N(of)---------------------+---------COMP:N-N(of)--------+-------COMP:N-N(of)-------+                                  
      |          |     +----MOD_ATT:N-ADJ---+---------COMP:N-N(with)--------+COMP:N-N(of+                       +-----------COMP:N-N(of)-----------+              +--------COMP:N-N(of)--------+                         |          +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+------COMP:N-N(after)------+      
      |          |     |        +MOD_ATT:N-A+-COMP:N-N(of)-+                |      +MOD_+              +MOD_ATT:+COMP:N-N(o+           +MOD_ATT:N-A+-COMP:N-N(of)-+-COMP:N-N(with)-+           |                +MOD_ATT:+          |        +MOD_ATT:N+           |       +MOD_AT+      +MOD:+      +MOD_ATT:+      
      |          |     |        |           |              |                |      |    |              |        |          |           |           |              |                |           |                |        |          |        |         |           |       |      |      |    |      |        |      
 In liver from male __SP__ , dietary administration of __NODE__ ( with a dosage of 1 percent and a treatment period of 1 week ) and dietary administration of __NODE__ ( with a dosage of 00.2percent and a treatment period of 1 week ) decrease expression of __SP__ __NODE__ mRNA 1 week after initial treatment .
COMP:N-N(from) (liver,administration)
MOD_ATT:N-N (administration,male)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-ADJ (administration,dietary)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (administration,dosage)
COMP:N-N(with) (administration,period)
COMP:N-N(of) (dosage,percent)
MOD_ATT:N-ADJ (percent,1)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
COMP:N-N(of) (period,administration)
COMP:N-N(of) (week,__NODE__)
MOD_ATT:N-ADJ (administration,dietary)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (__NODE__,dosage)
COMP:N-N(of) (__NODE__,00.2percent)
COMP:N-N(of) (__NODE__,period)
COMP:N-N(of) (00.2percent,expression)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,expression)
MOD_ATT:N-N (expression,week)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD:ADV-N (after,week)
MOD_ATT:N-N (treatment,initial)

Analyse 3

      +------------COMP:N-N(from)-----------+                                                                                                                                                  +----------------------COMP:N-N(of)---------------------+                                                             
      |          +-------MOD_ATT:N-ADJ------+                               +------------COMP:N-N(of)-----------+          +-------------COMP:N-N(of)-------------+---------------------COMP:N-N(of)---------------------+---------COMP:N-N(of)--------+-------COMP:N-N(of)-------+                                  
      |          |     +----MOD_ATT:N-ADJ---+                               +COMP:N-N(of+                       +-----------COMP:N-N(of)-----------+              +--------COMP:N-N(of)--------+                         |          +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+------COMP:N-N(after)------+      
      |          |     |        +MOD_ATT:N-A+-COMP:N-N(of)-+------APPOS-----+      +MOD_+              +MOD_ATT:+COMP:N-N(o+           +MOD_ATT:N-A+-COMP:N-N(of)-+-COMP:N-N(with)-+           |                +MOD_ATT:+          |        +MOD_ATT:N+           |       +MOD_AT+      +MOD:+      +MOD_ATT:+      
      |          |     |        |           |              |                |      |    |              |        |          |           |           |              |                |           |                |        |          |        |         |           |       |      |      |    |      |        |      
 In liver from male __SP__ , dietary administration of __NODE__ ( with a dosage of 1 percent and a treatment period of 1 week ) and dietary administration of __NODE__ ( with a dosage of 00.2percent and a treatment period of 1 week ) decrease expression of __SP__ __NODE__ mRNA 1 week after initial treatment .
COMP:N-N(from) (liver,administration)
MOD_ATT:N-ADJ (administration,male)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-ADJ (administration,dietary)
COMP:N-N(of) (administration,__NODE__)
APPOS (__NODE__,dosage)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,1)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
COMP:N-N(of) (period,administration)
COMP:N-N(of) (week,__NODE__)
MOD_ATT:N-ADJ (administration,dietary)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (__NODE__,dosage)
COMP:N-N(of) (__NODE__,00.2percent)
COMP:N-N(of) (__NODE__,period)
COMP:N-N(of) (00.2percent,expression)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,expression)
MOD_ATT:N-N (expression,week)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD:ADV-N (after,week)
MOD_ATT:N-N (treatment,initial)

Analyse 4

      +------------COMP:N-N(from)-----------+                                                                              +---------------------COMP:N-N(with)--------------------+           +----------------------COMP:N-N(of)---------------------+                                                             
      |          +-------MOD_ATT:N-ADJ------+                               +------------COMP:N-N(of)-----------+          +-------------COMP:N-N(of)-------------+                |           |                         +---------COMP:N-N(of)--------+-------COMP:N-N(of)-------+                                  
      |          |     +----MOD_ATT:N-ADJ---+-------------APPOS-------------+COMP:N-N(of+                       +-----------COMP:N-N(of)-----------+---------COMP:N-N(with)--------+-------------COMP:N-N(of)------------+          +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+------COMP:N-N(after)------+      
      |          |     |        +MOD_ATT:N-A+-COMP:N-N(of)-+                |      +MOD_+              +MOD_ATT:+COMP:N-N(o+           +MOD_ATT:N-A+-COMP:N-N(of)-+                +COMP:N-N(of+                +MOD_ATT:+          |        +MOD_ATT:N+           |       +MOD_AT+      +MOD:+      +MOD_ATT:+      
      |          |     |        |           |              |                |      |    |              |        |          |           |           |              |                |           |                |        |          |        |         |           |       |      |      |    |      |        |      
 In liver from male __SP__ , dietary administration of __NODE__ ( with a dosage of 1 percent and a treatment period of 1 week ) and dietary administration of __NODE__ ( with a dosage of 00.2percent and a treatment period of 1 week ) decrease expression of __SP__ __NODE__ mRNA 1 week after initial treatment .
COMP:N-N(from) (liver,administration)
MOD_ATT:N-ADJ (administration,male)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-ADJ (administration,dietary)
COMP:N-N(of) (administration,__NODE__)
APPOS (administration,dosage)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,1)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
COMP:N-N(of) (period,administration)
COMP:N-N(of) (week,__NODE__)
COMP:N-N(with) (week,dosage)
MOD_ATT:N-ADJ (administration,dietary)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (administration,dosage)
COMP:N-N(of) (dosage,00.2percent)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (00.2percent,expression)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,expression)
MOD_ATT:N-N (expression,week)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD:ADV-N (after,week)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 5

                                                                                        +-----------------------COMP:N-N(of)-----------------------+                                                                                                                                                                 
      +------------COMP:N-N(from)-----------+                               +------------COMP:N-N(of)-----------+                                  |                                                                                                                                                                 
      |          +--------MOD_ATT:N-N-------+                               |           +-----------COMP:N-N(of)-----------+                       |              +---------------------COMP:N-N(of)---------------------+---------COMP:N-N(of)--------+-------COMP:N-N(of)-------+                                  
      |          |     +----MOD_ATT:N-ADJ---+---------COMP:N-N(with)--------+COMP:N-N(of+                       +-----------COMP:N-N(of)-----------+              +--------COMP:N-N(of)--------+                         |          +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+------COMP:N-N(after)------+      
      |          |     |        +MOD_ATT:N-A+-COMP:N-N(of)-+                |      +MOD_+              +MOD_ATT:+COMP:N-N(o+           +MOD_ATT:N-A+-COMP:N-N(of)-+-COMP:N-N(with)-+           |                +MOD_ATT:+          |        +MOD_ATT:N+           |       +MOD_AT+      +MOD:+      +MOD_ATT:+      
      |          |     |        |           |              |                |      |    |              |        |          |           |           |              |                |           |                |        |          |        |         |           |       |      |      |    |      |        |      
 In liver from male __SP__ , dietary administration of __NODE__ ( with a dosage of 1 percent and a treatment period of 1 week ) and dietary administration of __NODE__ ( with a dosage of 00.2percent and a treatment period of 1 week ) decrease expression of __SP__ __NODE__ mRNA 1 week after initial treatment .
COMP:N-N(from) (liver,administration)
MOD_ATT:N-N (administration,male)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-ADJ (administration,dietary)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (administration,dosage)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,1)
COMP:N-N(of) (percent,week)
COMP:N-N(of) (percent,administration)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
COMP:N-N(of) (period,administration)
MOD_ATT:N-ADJ (administration,dietary)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (__NODE__,dosage)
COMP:N-N(of) (__NODE__,00.2percent)
COMP:N-N(of) (__NODE__,period)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,expression)
MOD_ATT:N-N (expression,week)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD:ADV-N (after,week)
MOD_ATT:N-N (treatment,initial)

Analyse 6

      +------------COMP:N-N(from)-----------+                                                                                                                                                                                                                                                                        
      |          +-------MOD_ATT:N-ADJ------+              +-------------------COMP:N-N(with)-------------------+                                                                                                        +---------COMP:N-N(of)--------+-------COMP:N-N(of)-------+                                  
      |          |     +----MOD_ATT:N-ADJ---+              |                +COMP:N-N(of+                       +-----------COMP:N-N(of)-----------+-------------APPOS-------------+-------------COMP:N-N(of)------------+          +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+------COMP:N-N(after)------+      
      |          |     |        +MOD_ATT:N-A+-COMP:N-N(of)-+-COMP:N-N(with)-+      +MOD_+              +MOD_ATT:+COMP:N-N(o+           +MOD_ATT:N-A+-COMP:N-N(of)-+                +COMP:N-N(of+                +MOD_ATT:+          |        +MOD_ATT:N+           |       +MOD_AT+      +MOD:+      +MOD_ATT:+      
      |          |     |        |           |              |                |      |    |              |        |          |           |           |              |                |           |                |        |          |        |         |           |       |      |      |    |      |        |      
 In liver from male __SP__ , dietary administration of __NODE__ ( with a dosage of 1 percent and a treatment period of 1 week ) and dietary administration of __NODE__ ( with a dosage of 00.2percent and a treatment period of 1 week ) decrease expression of __SP__ __NODE__ mRNA 1 week after initial treatment .
COMP:N-N(from) (liver,administration)
MOD_ATT:N-ADJ (administration,male)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-ADJ (administration,dietary)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (__NODE__,dosage)
COMP:N-N(with) (__NODE__,period)
COMP:N-N(of) (dosage,percent)
MOD_ATT:N-ADJ (percent,1)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
COMP:N-N(of) (period,administration)
MOD_ATT:N-ADJ (administration,dietary)
COMP:N-N(of) (administration,__NODE__)
APPOS (administration,dosage)
COMP:N-N(of) (dosage,00.2percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,expression)
MOD_ATT:N-N (expression,week)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD:ADV-N (after,week)
MOD_ATT:N-N (treatment,initial)

Analyse 7

                                                                                        +-----------------------COMP:N-N(of)-----------------------+                                                                                                                                                                 
                                                                            +------------COMP:N-N(of)-----------+                                  |                                           +----------------------COMP:N-N(of)---------------------+                                                             
                                                                            |           +-----------COMP:N-N(of)-----------+-------------COMP:N-N(of)-------------+---------------------COMP:N-N(of)---------------------+---------COMP:N-N(of)--------+-------COMP:N-N(of)-------+                                  
      +-COMP:N-N(from)-+--------APPOS-------+                               +COMP:N-N(of+                       +-----------COMP:N-N(of)-----------+              +--------COMP:N-N(of)--------+                         |          +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+------COMP:N-N(after)------+      
      |          +MOD_A+        +MOD_ATT:N-A+-COMP:N-N(of)-+-COMP:N-N(with)-+      +MOD_+              +MOD_ATT:+COMP:N-N(o+           +MOD_ATT:N-A+-COMP:N-N(of)-+-COMP:N-N(with)-+           |                +MOD_ATT:+          |        +MOD_ATT:N+           |       +MOD_AT+      +MOD:+      +MOD_ATT:+      
      |          |     |        |           |              |                |      |    |              |        |          |           |           |              |                |           |                |        |          |        |         |           |       |      |      |    |      |        |      
 In liver from male __SP__ , dietary administration of __NODE__ ( with a dosage of 1 percent and a treatment period of 1 week ) and dietary administration of __NODE__ ( with a dosage of 00.2percent and a treatment period of 1 week ) decrease expression of __SP__ __NODE__ mRNA 1 week after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
APPOS (__SP__,administration)
MOD_ATT:N-ADJ (administration,dietary)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (__NODE__,dosage)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,1)
COMP:N-N(of) (percent,week)
COMP:N-N(of) (percent,administration)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
COMP:N-N(of) (period,administration)
COMP:N-N(of) (week,__NODE__)
MOD_ATT:N-ADJ (administration,dietary)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (__NODE__,dosage)
COMP:N-N(of) (__NODE__,00.2percent)
COMP:N-N(of) (__NODE__,period)
COMP:N-N(of) (00.2percent,expression)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,expression)
MOD_ATT:N-N (expression,week)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD:ADV-N (after,week)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 8

                                                                                        +-----------------------COMP:N-N(of)-----------------------+                                                                                                                                                                 
                                                                            +------------COMP:N-N(of)-----------+                                  |                                           +----------------------COMP:N-N(of)---------------------+                                                             
                                                                            |           +-----------COMP:N-N(of)-----------+-------------COMP:N-N(of)-------------+---------------------COMP:N-N(of)---------------------+---------COMP:N-N(of)--------+-------COMP:N-N(of)-------+                                  
      +-COMP:N-N(from)-+--------APPOS-------+---------COMP:N-N(with)--------+COMP:N-N(of+                       +-----------COMP:N-N(of)-----------+              +--------COMP:N-N(of)--------+                         |          +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+------COMP:N-N(after)------+      
      |          +MOD_A+        +MOD_ATT:N-A+-COMP:N-N(of)-+                |      +MOD_+              +MOD_ATT:+COMP:N-N(o+           +MOD_ATT:N-A+-COMP:N-N(of)-+-COMP:N-N(with)-+           |                +MOD_ATT:+          |        +MOD_ATT:N+           |       +MOD_AT+      +MOD:+      +MOD_ATT:+      
      |          |     |        |           |              |                |      |    |              |        |          |           |           |              |                |           |                |        |          |        |         |           |       |      |      |    |      |        |      
 In liver from male __SP__ , dietary administration of __NODE__ ( with a dosage of 1 percent and a treatment period of 1 week ) and dietary administration of __NODE__ ( with a dosage of 00.2percent and a treatment period of 1 week ) decrease expression of __SP__ __NODE__ mRNA 1 week after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
APPOS (__SP__,administration)
MOD_ATT:N-ADJ (administration,dietary)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (administration,dosage)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,1)
COMP:N-N(of) (percent,week)
COMP:N-N(of) (percent,administration)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
COMP:N-N(of) (period,administration)
COMP:N-N(of) (week,__NODE__)
MOD_ATT:N-ADJ (administration,dietary)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (__NODE__,dosage)
COMP:N-N(of) (__NODE__,00.2percent)
COMP:N-N(of) (__NODE__,period)
COMP:N-N(of) (00.2percent,expression)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,expression)
MOD_ATT:N-N (expression,week)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD:ADV-N (after,week)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 9

                                                                                        +-----------------------COMP:N-N(of)-----------------------+                                                                                                                                                                 
                                                                            +------------COMP:N-N(of)-----------+          +---------------------COMP:N-N(with)--------------------+           +----------------------COMP:N-N(of)---------------------+                                                             
      +----------------APPOS----------------+                               |           +-----------COMP:N-N(of)-----------+-------------COMP:N-N(of)-------------+                |           |                         +---------COMP:N-N(of)--------+-------COMP:N-N(of)-------+                                  
      +-COMP:N-N(from)-+                    |                               +COMP:N-N(of+                       +-----------COMP:N-N(of)-----------+---------COMP:N-N(with)--------+-------------COMP:N-N(of)------------+          +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+------COMP:N-N(after)------+      
      |          +MOD_A+        +MOD_ATT:N-A+-COMP:N-N(of)-+-COMP:N-N(with)-+      +MOD_+              +MOD_ATT:+COMP:N-N(o+           +MOD_ATT:N-A+-COMP:N-N(of)-+                +COMP:N-N(of+                +MOD_ATT:+          |        +MOD_ATT:N+           |       +MOD_AT+      +MOD:+      +MOD_ATT:+      
      |          |     |        |           |              |                |      |    |              |        |          |           |           |              |                |           |                |        |          |        |         |           |       |      |      |    |      |        |      
 In liver from male __SP__ , dietary administration of __NODE__ ( with a dosage of 1 percent and a treatment period of 1 week ) and dietary administration of __NODE__ ( with a dosage of 00.2percent and a treatment period of 1 week ) decrease expression of __SP__ __NODE__ mRNA 1 week after initial treatment .
COMP:N-N(from) (liver,__SP__)
APPOS (liver,administration)
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (administration,dietary)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (__NODE__,dosage)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,1)
COMP:N-N(of) (percent,week)
COMP:N-N(of) (percent,administration)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
COMP:N-N(of) (period,administration)
COMP:N-N(of) (week,__NODE__)
COMP:N-N(with) (week,dosage)
MOD_ATT:N-ADJ (administration,dietary)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (administration,dosage)
COMP:N-N(of) (dosage,00.2percent)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (00.2percent,expression)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,expression)
MOD_ATT:N-N (expression,week)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD:ADV-N (after,week)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 10

                                                                                        +-----------------------COMP:N-N(of)-----------------------+                                                                                                                                                                 
                                                           +--------------------COMP:N-N(of)--------------------+                                  |                                                                                                                                                                 
                                                           |                            +-----------COMP:N-N(of)-----------+-------------COMP:N-N(of)-------------+                                                      +---------COMP:N-N(of)--------+-------COMP:N-N(of)-------+                                  
      +-COMP:N-N(from)-+--------APPOS-------+              +--------COMP:N-N(of)--------+                       +-----------COMP:N-N(of)-----------+              +--------------------COMP:N-N(with)--------------------+          +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+------COMP:N-N(after)------+      
      |          +MOD_A+        +MOD_ATT:N-A+-COMP:N-N(of)-+-COMP:N-N(with)-+      +MOD_+              +MOD_ATT:+COMP:N-N(o+           +MOD_ATT:N-A+-COMP:N-N(of)-+-COMP:N-N(with)-+COMP:N-N(of+                +MOD_ATT:+          |        +MOD_ATT:N+           |       +MOD_AT+      +MOD:+      +MOD_ATT:+      
      |          |     |        |           |              |                |      |    |              |        |          |           |           |              |                |           |                |        |          |        |         |           |       |      |      |    |      |        |      
 In liver from male __SP__ , dietary administration of __NODE__ ( with a dosage of 1 percent and a treatment period of 1 week ) and dietary administration of __NODE__ ( with a dosage of 00.2percent and a treatment period of 1 week ) decrease expression of __SP__ __NODE__ mRNA 1 week after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
APPOS (__SP__,administration)
MOD_ATT:N-ADJ (administration,dietary)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (__NODE__,dosage)
COMP:N-N(of) (__NODE__,percent)
COMP:N-N(of) (__NODE__,period)
MOD_ATT:N-ADJ (percent,1)
COMP:N-N(of) (percent,week)
COMP:N-N(of) (percent,administration)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
COMP:N-N(of) (period,administration)
COMP:N-N(of) (week,__NODE__)
MOD_ATT:N-ADJ (administration,dietary)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (__NODE__,dosage)
COMP:N-N(with) (__NODE__,period)
COMP:N-N(of) (dosage,00.2percent)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,expression)
MOD_ATT:N-N (expression,week)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD:ADV-N (after,week)
MOD_ATT:N-N (treatment,initial)

Analyse 11

                                                                                        +-----------------------COMP:N-N(of)-----------------------+                                                                                                                                                                 
                                                           +--------------------COMP:N-N(of)--------------------+                                  |                                                                                                                                                                 
      +----------------APPOS----------------+              |                            +-----------COMP:N-N(of)-----------+-------------COMP:N-N(of)-------------+                                                      +---------COMP:N-N(of)--------+-------COMP:N-N(of)-------+                                  
      +-COMP:N-N(from)-+                    |              +--------COMP:N-N(of)--------+                       +-----------COMP:N-N(of)-----------+              +--------------------COMP:N-N(with)--------------------+          +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+------COMP:N-N(after)------+      
      |          +MOD_A+        +MOD_ATT:N-A+-COMP:N-N(of)-+-COMP:N-N(with)-+      +MOD_+              +MOD_ATT:+COMP:N-N(o+           +MOD_ATT:N-A+-COMP:N-N(of)-+-COMP:N-N(with)-+COMP:N-N(of+                +MOD_ATT:+          |        +MOD_ATT:N+           |       +MOD_AT+      +MOD:+      +MOD_ATT:+      
      |          |     |        |           |              |                |      |    |              |        |          |           |           |              |                |           |                |        |          |        |         |           |       |      |      |    |      |        |      
 In liver from male __SP__ , dietary administration of __NODE__ ( with a dosage of 1 percent and a treatment period of 1 week ) and dietary administration of __NODE__ ( with a dosage of 00.2percent and a treatment period of 1 week ) decrease expression of __SP__ __NODE__ mRNA 1 week after initial treatment .
COMP:N-N(from) (liver,__SP__)
APPOS (liver,administration)
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (administration,dietary)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (__NODE__,dosage)
COMP:N-N(of) (__NODE__,percent)
COMP:N-N(of) (__NODE__,period)
MOD_ATT:N-ADJ (percent,1)
COMP:N-N(of) (percent,week)
COMP:N-N(of) (percent,administration)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
COMP:N-N(of) (period,administration)
COMP:N-N(of) (week,__NODE__)
MOD_ATT:N-ADJ (administration,dietary)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (__NODE__,dosage)
COMP:N-N(with) (__NODE__,period)
COMP:N-N(of) (dosage,00.2percent)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,expression)
MOD_ATT:N-N (expression,week)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD:ADV-N (after,week)
MOD_ATT:N-N (treatment,initial)

Analyse 12

                                                                                                                           +----------------------------------------COMP:N-N(with)---------------------------------------+                                                                                           
                                                                                        +-----------------------COMP:N-N(of)-----------------------+----------------------------COMP:N-N(with)---------------------------+                                                                                           
                                                           +--------------------COMP:N-N(of)--------------------+          +---------------------COMP:N-N(with)--------------------+                                     |                                                                                           
                                                           |                            +-----------COMP:N-N(of)-----------+-------------COMP:N-N(of)-------------+                |                                     +---------COMP:N-N(of)--------+-------COMP:N-N(of)-------+                                  
      +-COMP:N-N(from)-+--------APPOS-------+              +--------COMP:N-N(of)--------+                       +-----------COMP:N-N(of)-----------+---------COMP:N-N(with)--------+                                     |          +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+------COMP:N-N(after)------+      
      |          +MOD_A+        +MOD_ATT:N-A+-COMP:N-N(of)-+-COMP:N-N(with)-+      +MOD_+              +MOD_ATT:+COMP:N-N(o+           +MOD_ATT:N-A+-COMP:N-N(of)-+                +COMP:N-N(of+                +MOD_ATT:+          |        +MOD_ATT:N+           |       +MOD_AT+      +MOD:+      +MOD_ATT:+      
      |          |     |        |           |              |                |      |    |              |        |          |           |           |              |                |           |                |        |          |        |         |           |       |      |      |    |      |        |      
 In liver from male __SP__ , dietary administration of __NODE__ ( with a dosage of 1 percent and a treatment period of 1 week ) and dietary administration of __NODE__ ( with a dosage of 00.2percent and a treatment period of 1 week ) decrease expression of __SP__ __NODE__ mRNA 1 week after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
APPOS (__SP__,administration)
MOD_ATT:N-ADJ (administration,dietary)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (__NODE__,dosage)
COMP:N-N(of) (__NODE__,percent)
COMP:N-N(of) (__NODE__,period)
MOD_ATT:N-ADJ (percent,1)
COMP:N-N(of) (percent,week)
COMP:N-N(of) (percent,administration)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
COMP:N-N(of) (period,administration)
COMP:N-N(of) (week,__NODE__)
COMP:N-N(with) (week,dosage)
COMP:N-N(with) (week,period)
MOD_ATT:N-ADJ (administration,dietary)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (administration,dosage)
COMP:N-N(with) (administration,period)
COMP:N-N(of) (dosage,00.2percent)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,expression)
MOD_ATT:N-N (expression,week)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD:ADV-N (after,week)
MOD_ATT:N-N (treatment,initial)

Analyse 13

      +------------COMP:N-N(from)-----------+                                                                                                                                                  +----------------------COMP:N-N(of)---------------------+                                                             
      |          +-------MOD_ATT:N-ADJ------+                               +------------COMP:N-N(of)-----------+                                                                              |                         +---------COMP:N-N(of)--------+-------COMP:N-N(of)-------+                                  
      |          |     +----MOD_ATT:N-ADJ---+                               +COMP:N-N(of+-----------COMP:N-N(of)-----------+-------------COMP:N-N(of)-------------+                +-------------COMP:N-N(of)------------+          +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+------COMP:N-N(after)------+      
      |          |     |        +MOD_ATT:N-A+-COMP:N-N(of)-+-COMP:N-N(with)-+      +MOD_+              +MOD_ATT:+COMP:N-N(o+           +MOD_ATT:N-A+-COMP:N-N(of)-+-COMP:N-N(with)-+COMP:N-N(of+                +MOD_ATT:+          |        +MOD_ATT:N+           |       +MOD_AT+      +MOD:+      +MOD_ATT:+      
      |          |     |        |           |              |                |      |    |              |        |          |           |           |              |                |           |                |        |          |        |         |           |       |      |      |    |      |        |      
 In liver from male __SP__ , dietary administration of __NODE__ ( with a dosage of 1 percent and a treatment period of 1 week ) and dietary administration of __NODE__ ( with a dosage of 00.2percent and a treatment period of 1 week ) decrease expression of __SP__ __NODE__ mRNA 1 week after initial treatment .
COMP:N-N(from) (liver,administration)
MOD_ATT:N-ADJ (administration,male)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-ADJ (administration,dietary)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (__NODE__,dosage)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,1)
COMP:N-N(of) (percent,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
COMP:N-N(of) (week,__NODE__)
MOD_ATT:N-ADJ (administration,dietary)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (__NODE__,dosage)
COMP:N-N(of) (dosage,00.2percent)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (00.2percent,expression)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,expression)
MOD_ATT:N-N (expression,week)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD:ADV-N (after,week)
MOD_ATT:N-N (treatment,initial)

Analyse 14

      +------------COMP:N-N(from)-----------+                                                                                                                                                  +----------------------COMP:N-N(of)---------------------+                                                             
      |          +-------MOD_ATT:N-ADJ------+              +--------------------COMP:N-N(of)--------------------+                                                                              |                         +---------COMP:N-N(of)--------+-------COMP:N-N(of)-------+                                  
      |          |     +----MOD_ATT:N-ADJ---+              +--------COMP:N-N(of)--------+-----------COMP:N-N(of)-----------+-------------COMP:N-N(of)-------------+                +-------------COMP:N-N(of)------------+          +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+------COMP:N-N(after)------+      
      |          |     |        +MOD_ATT:N-A+-COMP:N-N(of)-+-COMP:N-N(with)-+      +MOD_+              +MOD_ATT:+COMP:N-N(o+           +MOD_ATT:N-A+-COMP:N-N(of)-+-COMP:N-N(with)-+COMP:N-N(of+                +MOD_ATT:+          |        +MOD_ATT:N+           |       +MOD_AT+      +MOD:+      +MOD_ATT:+      
      |          |     |        |           |              |                |      |    |              |        |          |           |           |              |                |           |                |        |          |        |         |           |       |      |      |    |      |        |      
 In liver from male __SP__ , dietary administration of __NODE__ ( with a dosage of 1 percent and a treatment period of 1 week ) and dietary administration of __NODE__ ( with a dosage of 00.2percent and a treatment period of 1 week ) decrease expression of __SP__ __NODE__ mRNA 1 week after initial treatment .
COMP:N-N(from) (liver,administration)
MOD_ATT:N-ADJ (administration,male)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-ADJ (administration,dietary)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (__NODE__,dosage)
COMP:N-N(of) (__NODE__,percent)
COMP:N-N(of) (__NODE__,period)
MOD_ATT:N-ADJ (percent,1)
COMP:N-N(of) (percent,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
COMP:N-N(of) (week,__NODE__)
MOD_ATT:N-ADJ (administration,dietary)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (__NODE__,dosage)
COMP:N-N(of) (dosage,00.2percent)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (00.2percent,expression)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,expression)
MOD_ATT:N-N (expression,week)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD:ADV-N (after,week)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 15

      +------------COMP:N-N(from)-----------+                                                                                                                                                  +----------------------COMP:N-N(of)---------------------+                                                             
      |          +-------MOD_ATT:N-ADJ------+              +--------------------COMP:N-N(of)--------------------+                                                 +---------------------COMP:N-N(of)---------------------+---------COMP:N-N(of)--------+-------COMP:N-N(of)-------+                                  
      |          |     +----MOD_ATT:N-ADJ---+              +--------COMP:N-N(of)--------+-----------COMP:N-N(of)-----------+-------------COMP:N-N(of)-------------+--------COMP:N-N(of)--------+                         |          +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+------COMP:N-N(after)------+      
      |          |     |        +MOD_ATT:N-A+-COMP:N-N(of)-+-COMP:N-N(with)-+      +MOD_+              +MOD_ATT:+COMP:N-N(o+           +MOD_ATT:N-A+-COMP:N-N(of)-+-COMP:N-N(with)-+           |                +MOD_ATT:+          |        +MOD_ATT:N+           |       +MOD_AT+      +MOD:+      +MOD_ATT:+      
      |          |     |        |           |              |                |      |    |              |        |          |           |           |              |                |           |                |        |          |        |         |           |       |      |      |    |      |        |      
 In liver from male __SP__ , dietary administration of __NODE__ ( with a dosage of 1 percent and a treatment period of 1 week ) and dietary administration of __NODE__ ( with a dosage of 00.2percent and a treatment period of 1 week ) decrease expression of __SP__ __NODE__ mRNA 1 week after initial treatment .
COMP:N-N(from) (liver,administration)
MOD_ATT:N-ADJ (administration,male)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-ADJ (administration,dietary)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (__NODE__,dosage)
COMP:N-N(of) (__NODE__,percent)
COMP:N-N(of) (__NODE__,period)
MOD_ATT:N-ADJ (percent,1)
COMP:N-N(of) (percent,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
COMP:N-N(of) (week,__NODE__)
MOD_ATT:N-ADJ (administration,dietary)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (__NODE__,dosage)
COMP:N-N(of) (__NODE__,00.2percent)
COMP:N-N(of) (__NODE__,period)
COMP:N-N(of) (00.2percent,expression)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,expression)
MOD_ATT:N-N (expression,week)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD:ADV-N (after,week)
MOD_ATT:N-N (treatment,initial)

Analyse 16

                                                                                        +-----------------------COMP:N-N(of)-----------------------+                                                                                                                                                                 
                                                           +--------------------COMP:N-N(of)--------------------+                                  |                                           +----------------------COMP:N-N(of)---------------------+                                                             
      +----------------APPOS----------------+              |                            +-----------COMP:N-N(of)-----------+                       |                                           |                         +---------COMP:N-N(of)--------+-------COMP:N-N(of)-------+                                  
      +-COMP:N-N(from)-+                    |              +--------COMP:N-N(of)--------+                       +-----------COMP:N-N(of)-----------+---------COMP:N-N(with)--------+-------------COMP:N-N(of)------------+          +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+------COMP:N-N(after)------+      
      |          +MOD_A+        +MOD_ATT:N-A+-COMP:N-N(of)-+-COMP:N-N(with)-+      +MOD_+              +MOD_ATT:+COMP:N-N(o+           +MOD_ATT:N-A+-COMP:N-N(of)-+                +COMP:N-N(of+                +MOD_ATT:+          |        +MOD_ATT:N+           |       +MOD_AT+      +MOD:+      +MOD_ATT:+      
      |          |     |        |           |              |                |      |    |              |        |          |           |           |              |                |           |                |        |          |        |         |           |       |      |      |    |      |        |      
 In liver from male __SP__ , dietary administration of __NODE__ ( with a dosage of 1 percent and a treatment period of 1 week ) and dietary administration of __NODE__ ( with a dosage of 00.2percent and a treatment period of 1 week ) decrease expression of __SP__ __NODE__ mRNA 1 week after initial treatment .
COMP:N-N(from) (liver,__SP__)
APPOS (liver,administration)
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (administration,dietary)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (__NODE__,dosage)
COMP:N-N(of) (__NODE__,percent)
COMP:N-N(of) (__NODE__,period)
MOD_ATT:N-ADJ (percent,1)
COMP:N-N(of) (percent,week)
COMP:N-N(of) (percent,administration)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
COMP:N-N(of) (period,administration)
MOD_ATT:N-ADJ (administration,dietary)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (administration,dosage)
COMP:N-N(of) (dosage,00.2percent)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (00.2percent,expression)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,expression)
MOD_ATT:N-N (expression,week)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD:ADV-N (after,week)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 17

                                                                                        +-----------------------COMP:N-N(of)-----------------------+                                                                                                                                                                 
                                                                            +------------COMP:N-N(of)-----------+                                  |                                           +----------------------COMP:N-N(of)---------------------+                                                             
                                                                            |           +-----------COMP:N-N(of)-----------+                       |                                           |                         +---------COMP:N-N(of)--------+-------COMP:N-N(of)-------+                                  
      +-COMP:N-N(from)-+--------APPOS-------+                               +COMP:N-N(of+                       +-----------COMP:N-N(of)-----------+---------COMP:N-N(with)--------+-------------COMP:N-N(of)------------+          +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+------COMP:N-N(after)------+      
      |          +MOD_A+        +MOD_ATT:N-A+-COMP:N-N(of)-+-COMP:N-N(with)-+      +MOD_+              +MOD_ATT:+COMP:N-N(o+           +MOD_ATT:N-A+-COMP:N-N(of)-+                +COMP:N-N(of+                +MOD_ATT:+          |        +MOD_ATT:N+           |       +MOD_AT+      +MOD:+      +MOD_ATT:+      
      |          |     |        |           |              |                |      |    |              |        |          |           |           |              |                |           |                |        |          |        |         |           |       |      |      |    |      |        |      
 In liver from male __SP__ , dietary administration of __NODE__ ( with a dosage of 1 percent and a treatment period of 1 week ) and dietary administration of __NODE__ ( with a dosage of 00.2percent and a treatment period of 1 week ) decrease expression of __SP__ __NODE__ mRNA 1 week after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
APPOS (__SP__,administration)
MOD_ATT:N-ADJ (administration,dietary)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (__NODE__,dosage)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,1)
COMP:N-N(of) (percent,week)
COMP:N-N(of) (percent,administration)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
COMP:N-N(of) (period,administration)
MOD_ATT:N-ADJ (administration,dietary)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (administration,dosage)
COMP:N-N(of) (dosage,00.2percent)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (00.2percent,expression)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,expression)
MOD_ATT:N-N (expression,week)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD:ADV-N (after,week)
MOD_ATT:N-N (treatment,initial)

Analyse 18

                                                                                        +-----------------------COMP:N-N(of)-----------------------+                                                                                                                                                                 
      +------------COMP:N-N(from)-----------+                               +------------COMP:N-N(of)-----------+                                  |                                           +----------------------COMP:N-N(of)---------------------+                                                             
      |          +-------MOD_ATT:N-ADJ------+                               |           +-----------COMP:N-N(of)-----------+-------------COMP:N-N(of)-------------+                            |                         +---------COMP:N-N(of)--------+-------COMP:N-N(of)-------+                                  
      |          |     +----MOD_ATT:N-ADJ---+---------COMP:N-N(with)--------+COMP:N-N(of+                       +-----------COMP:N-N(of)-----------+              +--------COMP:N-N(of)--------+                         |          +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+------COMP:N-N(after)------+      
      |          |     |        +MOD_ATT:N-A+-COMP:N-N(of)-+                |      +MOD_+              +MOD_ATT:+COMP:N-N(o+           +MOD_ATT:N-A+-COMP:N-N(of)-+-COMP:N-N(with)-+           |                +MOD_ATT:+          |        +MOD_ATT:N+           |       +MOD_AT+      +MOD:+      +MOD_ATT:+      
      |          |     |        |           |              |                |      |    |              |        |          |           |           |              |                |           |                |        |          |        |         |           |       |      |      |    |      |        |      
 In liver from male __SP__ , dietary administration of __NODE__ ( with a dosage of 1 percent and a treatment period of 1 week ) and dietary administration of __NODE__ ( with a dosage of 00.2percent and a treatment period of 1 week ) decrease expression of __SP__ __NODE__ mRNA 1 week after initial treatment .
COMP:N-N(from) (liver,administration)
MOD_ATT:N-ADJ (administration,male)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-ADJ (administration,dietary)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (administration,dosage)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,1)
COMP:N-N(of) (percent,week)
COMP:N-N(of) (percent,administration)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
COMP:N-N(of) (period,administration)
COMP:N-N(of) (week,__NODE__)
MOD_ATT:N-ADJ (administration,dietary)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (__NODE__,dosage)
COMP:N-N(of) (__NODE__,00.2percent)
COMP:N-N(of) (00.2percent,expression)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,expression)
MOD_ATT:N-N (expression,week)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD:ADV-N (after,week)
MOD_ATT:N-N (treatment,initial)

Analyse 19

                                                                                                                                                                                               +----------------------COMP:N-N(of)---------------------+                                                             
      +----------------APPOS----------------+                               +------------COMP:N-N(of)-----------+          +-------------COMP:N-N(of)-------------+                            |                         +---------COMP:N-N(of)--------+-------COMP:N-N(of)-------+                                  
      +-COMP:N-N(from)-+                    +---------COMP:N-N(with)--------+COMP:N-N(of+                       +-----------COMP:N-N(of)-----------+              |                +-------------COMP:N-N(of)------------+          +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+------COMP:N-N(after)------+      
      |          +MOD_A+        +MOD_ATT:N-A+-COMP:N-N(of)-+                |      +MOD_+              +MOD_ATT:+COMP:N-N(o+           +MOD_ATT:N-A+-COMP:N-N(of)-+-COMP:N-N(with)-+COMP:N-N(of+                +MOD_ATT:+          |        +MOD_ATT:N+           |       +MOD_AT+      +MOD:+      +MOD_ATT:+      
      |          |     |        |           |              |                |      |    |              |        |          |           |           |              |                |           |                |        |          |        |         |           |       |      |      |    |      |        |      
 In liver from male __SP__ , dietary administration of __NODE__ ( with a dosage of 1 percent and a treatment period of 1 week ) and dietary administration of __NODE__ ( with a dosage of 00.2percent and a treatment period of 1 week ) decrease expression of __SP__ __NODE__ mRNA 1 week after initial treatment .
COMP:N-N(from) (liver,__SP__)
APPOS (liver,administration)
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (administration,dietary)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (administration,dosage)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,1)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
COMP:N-N(of) (period,administration)
COMP:N-N(of) (week,__NODE__)
MOD_ATT:N-ADJ (administration,dietary)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (__NODE__,dosage)
COMP:N-N(of) (dosage,00.2percent)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (00.2percent,expression)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,expression)
MOD_ATT:N-N (expression,week)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD:ADV-N (after,week)
MOD_ATT:N-N (treatment,initial)

Analyse 20

      +------------COMP:N-N(from)-----------+                                           +-----------------------COMP:N-N(of)-----------------------+                                           +----------------------COMP:N-N(of)---------------------+                                                             
      |          +-------MOD_ATT:N-ADJ------+                                           +-----------COMP:N-N(of)-----------+                       |              +---------------------COMP:N-N(of)---------------------+---------COMP:N-N(of)--------+-------COMP:N-N(of)-------+                                  
      |          |     +----MOD_ATT:N-ADJ---+---------COMP:N-N(with)--------+COMP:N-N(of+                       +-----------COMP:N-N(of)-----------+              +--------COMP:N-N(of)--------+                         |          +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+------COMP:N-N(after)------+      
      |          |     |        +MOD_ATT:N-A+-COMP:N-N(of)-+                |      +MOD_+              +MOD_ATT:+COMP:N-N(o+           +MOD_ATT:N-A+-COMP:N-N(of)-+-COMP:N-N(with)-+           |                +MOD_ATT:+          |        +MOD_ATT:N+           |       +MOD_AT+      +MOD:+      +MOD_ATT:+      
      |          |     |        |           |              |                |      |    |              |        |          |           |           |              |                |           |                |        |          |        |         |           |       |      |      |    |      |        |      
 In liver from male __SP__ , dietary administration of __NODE__ ( with a dosage of 1 percent and a treatment period of 1 week ) and dietary administration of __NODE__ ( with a dosage of 00.2percent and a treatment period of 1 week ) decrease expression of __SP__ __NODE__ mRNA 1 week after initial treatment .
COMP:N-N(from) (liver,administration)
MOD_ATT:N-ADJ (administration,male)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-ADJ (administration,dietary)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (administration,dosage)
COMP:N-N(of) (dosage,percent)
MOD_ATT:N-ADJ (percent,1)
COMP:N-N(of) (percent,week)
COMP:N-N(of) (percent,administration)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
COMP:N-N(of) (period,administration)
MOD_ATT:N-ADJ (administration,dietary)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (__NODE__,dosage)
COMP:N-N(of) (__NODE__,00.2percent)
COMP:N-N(of) (__NODE__,period)
COMP:N-N(of) (00.2percent,expression)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,expression)
MOD_ATT:N-N (expression,week)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD:ADV-N (after,week)
MOD_ATT:N-N (treatment,initial)

Analyse 21

                                                                                        +-----------------------COMP:N-N(of)-----------------------+                                                                                                                                                                 
                                                           +--------------------COMP:N-N(of)--------------------+                                  |                                                                                                                                                                 
                                                           |                            +-----------COMP:N-N(of)-----------+                       |                                                                     +---------COMP:N-N(of)--------+-------COMP:N-N(of)-------+                                  
      +-COMP:N-N(from)-+--------APPOS-------+              +--------COMP:N-N(of)--------+                       +-----------COMP:N-N(of)-----------+              +--------------------COMP:N-N(with)--------------------+          +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+------COMP:N-N(after)------+      
      |          +MOD_A+        +MOD_ATT:N-A+-COMP:N-N(of)-+-COMP:N-N(with)-+      +MOD_+              +MOD_ATT:+COMP:N-N(o+           +MOD_ATT:N-A+-COMP:N-N(of)-+-COMP:N-N(with)-+COMP:N-N(of+                +MOD_ATT:+          |        +MOD_ATT:N+           |       +MOD_AT+      +MOD:+      +MOD_ATT:+      
      |          |     |        |           |              |                |      |    |              |        |          |           |           |              |                |           |                |        |          |        |         |           |       |      |      |    |      |        |      
 In liver from male __SP__ , dietary administration of __NODE__ ( with a dosage of 1 percent and a treatment period of 1 week ) and dietary administration of __NODE__ ( with a dosage of 00.2percent and a treatment period of 1 week ) decrease expression of __SP__ __NODE__ mRNA 1 week after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
APPOS (__SP__,administration)
MOD_ATT:N-ADJ (administration,dietary)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (__NODE__,dosage)
COMP:N-N(of) (__NODE__,percent)
COMP:N-N(of) (__NODE__,period)
MOD_ATT:N-ADJ (percent,1)
COMP:N-N(of) (percent,week)
COMP:N-N(of) (percent,administration)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
COMP:N-N(of) (period,administration)
MOD_ATT:N-ADJ (administration,dietary)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (__NODE__,dosage)
COMP:N-N(with) (__NODE__,period)
COMP:N-N(of) (dosage,00.2percent)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,expression)
MOD_ATT:N-N (expression,week)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD:ADV-N (after,week)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 22

                                            +---------------------------COMP:N-N(with)--------------------------+          +-------------COMP:N-N(of)-------------+                                                      +---------COMP:N-N(of)--------+-------COMP:N-N(of)-------+                                  
      +-COMP:N-N(from)-+--------APPOS-------+---------COMP:N-N(with)--------+COMP:N-N(of+                       +-----------COMP:N-N(of)-----------+              +--------------------COMP:N-N(with)--------------------+          +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+------COMP:N-N(after)------+      
      |          +MOD_A+        +MOD_ATT:N-A+-COMP:N-N(of)-+                |      +MOD_+              +MOD_ATT:+COMP:N-N(o+           +MOD_ATT:N-A+-COMP:N-N(of)-+-COMP:N-N(with)-+COMP:N-N(of+                +MOD_ATT:+          |        +MOD_ATT:N+           |       +MOD_AT+      +MOD:+      +MOD_ATT:+      
      |          |     |        |           |              |                |      |    |              |        |          |           |           |              |                |           |                |        |          |        |         |           |       |      |      |    |      |        |      
 In liver from male __SP__ , dietary administration of __NODE__ ( with a dosage of 1 percent and a treatment period of 1 week ) and dietary administration of __NODE__ ( with a dosage of 00.2percent and a treatment period of 1 week ) decrease expression of __SP__ __NODE__ mRNA 1 week after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
APPOS (__SP__,administration)
MOD_ATT:N-ADJ (administration,dietary)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (administration,dosage)
COMP:N-N(with) (administration,period)
COMP:N-N(of) (dosage,percent)
MOD_ATT:N-ADJ (percent,1)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
COMP:N-N(of) (period,administration)
COMP:N-N(of) (week,__NODE__)
MOD_ATT:N-ADJ (administration,dietary)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (__NODE__,dosage)
COMP:N-N(with) (__NODE__,period)
COMP:N-N(of) (dosage,00.2percent)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,expression)
MOD_ATT:N-N (expression,week)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD:ADV-N (after,week)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 23

      +----------------APPOS----------------+---------------------------COMP:N-N(with)--------------------------+          +-------------COMP:N-N(of)-------------+---------------------COMP:N-N(of)---------------------+---------COMP:N-N(of)--------+-------COMP:N-N(of)-------+                                  
      +-COMP:N-N(from)-+                    +---------COMP:N-N(with)--------+COMP:N-N(of+                       +-----------COMP:N-N(of)-----------+              +--------COMP:N-N(of)--------+                         |          +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+------COMP:N-N(after)------+      
      |          +MOD_A+        +MOD_ATT:N-A+-COMP:N-N(of)-+                |      +MOD_+              +MOD_ATT:+COMP:N-N(o+           +MOD_ATT:N-A+-COMP:N-N(of)-+-COMP:N-N(with)-+           |                +MOD_ATT:+          |        +MOD_ATT:N+           |       +MOD_AT+      +MOD:+      +MOD_ATT:+      
      |          |     |        |           |              |                |      |    |              |        |          |           |           |              |                |           |                |        |          |        |         |           |       |      |      |    |      |        |      
 In liver from male __SP__ , dietary administration of __NODE__ ( with a dosage of 1 percent and a treatment period of 1 week ) and dietary administration of __NODE__ ( with a dosage of 00.2percent and a treatment period of 1 week ) decrease expression of __SP__ __NODE__ mRNA 1 week after initial treatment .
COMP:N-N(from) (liver,__SP__)
APPOS (liver,administration)
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (administration,dietary)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (administration,dosage)
COMP:N-N(with) (administration,period)
COMP:N-N(of) (dosage,percent)
MOD_ATT:N-ADJ (percent,1)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
COMP:N-N(of) (period,administration)
COMP:N-N(of) (week,__NODE__)
MOD_ATT:N-ADJ (administration,dietary)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (__NODE__,dosage)
COMP:N-N(of) (__NODE__,00.2percent)
COMP:N-N(of) (__NODE__,period)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,expression)
MOD_ATT:N-N (expression,week)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD:ADV-N (after,week)
MOD_ATT:N-N (treatment,initial)

Analyse 24

      +----------------APPOS----------------+              +--------------------COMP:N-N(of)--------------------+          +-------------COMP:N-N(of)-------------+                                                      +---------COMP:N-N(of)--------+-------COMP:N-N(of)-------+                                  
      +-COMP:N-N(from)-+                    |              +--------COMP:N-N(of)--------+                       +-----------COMP:N-N(of)-----------+              |                +-------------COMP:N-N(of)------------+          +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+------COMP:N-N(after)------+      
      |          +MOD_A+        +MOD_ATT:N-A+-COMP:N-N(of)-+-COMP:N-N(with)-+      +MOD_+              +MOD_ATT:+COMP:N-N(o+           +MOD_ATT:N-A+-COMP:N-N(of)-+-COMP:N-N(with)-+COMP:N-N(of+                +MOD_ATT:+          |        +MOD_ATT:N+           |       +MOD_AT+      +MOD:+      +MOD_ATT:+      
      |          |     |        |           |              |                |      |    |              |        |          |           |           |              |                |           |                |        |          |        |         |           |       |      |      |    |      |        |      
 In liver from male __SP__ , dietary administration of __NODE__ ( with a dosage of 1 percent and a treatment period of 1 week ) and dietary administration of __NODE__ ( with a dosage of 00.2percent and a treatment period of 1 week ) decrease expression of __SP__ __NODE__ mRNA 1 week after initial treatment .
COMP:N-N(from) (liver,__SP__)
APPOS (liver,administration)
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (administration,dietary)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (__NODE__,dosage)
COMP:N-N(of) (__NODE__,percent)
COMP:N-N(of) (__NODE__,period)
MOD_ATT:N-ADJ (percent,1)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
COMP:N-N(of) (period,administration)
COMP:N-N(of) (week,__NODE__)
MOD_ATT:N-ADJ (administration,dietary)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (__NODE__,dosage)
COMP:N-N(of) (dosage,00.2percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,expression)
MOD_ATT:N-N (expression,week)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD:ADV-N (after,week)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 25

                                                                                                                           +---------------------COMP:N-N(with)--------------------+                                                                                                                                 
                                                           +--------------------COMP:N-N(of)--------------------+          +-------------COMP:N-N(of)-------------+                |                                     +---------COMP:N-N(of)--------+-------COMP:N-N(of)-------+                                  
      +-COMP:N-N(from)-+--------APPOS-------+              +--------COMP:N-N(of)--------+                       +-----------COMP:N-N(of)-----------+---------COMP:N-N(with)--------+-------------COMP:N-N(of)------------+          +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+------COMP:N-N(after)------+      
      |          +MOD_A+        +MOD_ATT:N-A+-COMP:N-N(of)-+-COMP:N-N(with)-+      +MOD_+              +MOD_ATT:+COMP:N-N(o+           +MOD_ATT:N-A+-COMP:N-N(of)-+                +COMP:N-N(of+                +MOD_ATT:+          |        +MOD_ATT:N+           |       +MOD_AT+      +MOD:+      +MOD_ATT:+      
      |          |     |        |           |              |                |      |    |              |        |          |           |           |              |                |           |                |        |          |        |         |           |       |      |      |    |      |        |      
 In liver from male __SP__ , dietary administration of __NODE__ ( with a dosage of 1 percent and a treatment period of 1 week ) and dietary administration of __NODE__ ( with a dosage of 00.2percent and a treatment period of 1 week ) decrease expression of __SP__ __NODE__ mRNA 1 week after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
APPOS (__SP__,administration)
MOD_ATT:N-ADJ (administration,dietary)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (__NODE__,dosage)
COMP:N-N(of) (__NODE__,percent)
COMP:N-N(of) (__NODE__,period)
MOD_ATT:N-ADJ (percent,1)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
COMP:N-N(of) (period,administration)
COMP:N-N(of) (week,__NODE__)
COMP:N-N(with) (week,dosage)
MOD_ATT:N-ADJ (administration,dietary)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (administration,dosage)
COMP:N-N(of) (dosage,00.2percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,expression)
MOD_ATT:N-N (expression,week)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD:ADV-N (after,week)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 26

                                                                                                                                                                                               +----------------------COMP:N-N(of)---------------------+                                                             
                                            +---------------------------COMP:N-N(with)--------------------------+                                                 +---------------------COMP:N-N(of)---------------------+---------COMP:N-N(of)--------+-------COMP:N-N(of)-------+                                  
      +-COMP:N-N(from)-+--------APPOS-------+---------COMP:N-N(with)--------+COMP:N-N(of+                       +-----------COMP:N-N(of)-----------+              +--------COMP:N-N(of)--------+                         |          +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+------COMP:N-N(after)------+      
      |          +MOD_A+        +MOD_ATT:N-A+-COMP:N-N(of)-+                |      +MOD_+              +MOD_ATT:+COMP:N-N(o+           +MOD_ATT:N-A+-COMP:N-N(of)-+-COMP:N-N(with)-+           |                +MOD_ATT:+          |        +MOD_ATT:N+           |       +MOD_AT+      +MOD:+      +MOD_ATT:+      
      |          |     |        |           |              |                |      |    |              |        |          |           |           |              |                |           |                |        |          |        |         |           |       |      |      |    |      |        |      
 In liver from male __SP__ , dietary administration of __NODE__ ( with a dosage of 1 percent and a treatment period of 1 week ) and dietary administration of __NODE__ ( with a dosage of 00.2percent and a treatment period of 1 week ) decrease expression of __SP__ __NODE__ mRNA 1 week after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
APPOS (__SP__,administration)
MOD_ATT:N-ADJ (administration,dietary)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (administration,dosage)
COMP:N-N(with) (administration,period)
COMP:N-N(of) (dosage,percent)
MOD_ATT:N-ADJ (percent,1)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
COMP:N-N(of) (period,administration)
MOD_ATT:N-ADJ (administration,dietary)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (__NODE__,dosage)
COMP:N-N(of) (__NODE__,00.2percent)
COMP:N-N(of) (__NODE__,period)
COMP:N-N(of) (00.2percent,expression)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,expression)
MOD_ATT:N-N (expression,week)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD:ADV-N (after,week)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 27

                                                                                                                                                                                               +----------------------COMP:N-N(of)---------------------+                                                             
                                                           +--------------------COMP:N-N(of)--------------------+                                                                              |                         +---------COMP:N-N(of)--------+-------COMP:N-N(of)-------+                                  
      +-COMP:N-N(from)-+--------APPOS-------+              +--------COMP:N-N(of)--------+                       +-----------COMP:N-N(of)-----------+---------COMP:N-N(with)--------+-------------COMP:N-N(of)------------+          +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+------COMP:N-N(after)------+      
      |          +MOD_A+        +MOD_ATT:N-A+-COMP:N-N(of)-+-COMP:N-N(with)-+      +MOD_+              +MOD_ATT:+COMP:N-N(o+           +MOD_ATT:N-A+-COMP:N-N(of)-+                +COMP:N-N(of+                +MOD_ATT:+          |        +MOD_ATT:N+           |       +MOD_AT+      +MOD:+      +MOD_ATT:+      
      |          |     |        |           |              |                |      |    |              |        |          |           |           |              |                |           |                |        |          |        |         |           |       |      |      |    |      |        |      
 In liver from male __SP__ , dietary administration of __NODE__ ( with a dosage of 1 percent and a treatment period of 1 week ) and dietary administration of __NODE__ ( with a dosage of 00.2percent and a treatment period of 1 week ) decrease expression of __SP__ __NODE__ mRNA 1 week after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
APPOS (__SP__,administration)
MOD_ATT:N-ADJ (administration,dietary)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (__NODE__,dosage)
COMP:N-N(of) (__NODE__,percent)
COMP:N-N(of) (__NODE__,period)
MOD_ATT:N-ADJ (percent,1)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
COMP:N-N(of) (period,administration)
MOD_ATT:N-ADJ (administration,dietary)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (administration,dosage)
COMP:N-N(of) (dosage,00.2percent)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (00.2percent,expression)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,expression)
MOD_ATT:N-N (expression,week)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD:ADV-N (after,week)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 28

                                                                                                                                                                                               +----------------------COMP:N-N(of)---------------------+                                                             
                                                                            +------------COMP:N-N(of)-----------+                                                                              |                         +---------COMP:N-N(of)--------+-------COMP:N-N(of)-------+                                  
      +-COMP:N-N(from)-+--------APPOS-------+---------COMP:N-N(with)--------+COMP:N-N(of+                       +-----------COMP:N-N(of)-----------+                               +-------------COMP:N-N(of)------------+          +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+------COMP:N-N(after)------+      
      |          +MOD_A+        +MOD_ATT:N-A+-COMP:N-N(of)-+                |      +MOD_+              +MOD_ATT:+COMP:N-N(o+           +MOD_ATT:N-A+-COMP:N-N(of)-+-COMP:N-N(with)-+COMP:N-N(of+                +MOD_ATT:+          |        +MOD_ATT:N+           |       +MOD_AT+      +MOD:+      +MOD_ATT:+      
      |          |     |        |           |              |                |      |    |              |        |          |           |           |              |                |           |                |        |          |        |         |           |       |      |      |    |      |        |      
 In liver from male __SP__ , dietary administration of __NODE__ ( with a dosage of 1 percent and a treatment period of 1 week ) and dietary administration of __NODE__ ( with a dosage of 00.2percent and a treatment period of 1 week ) decrease expression of __SP__ __NODE__ mRNA 1 week after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
APPOS (__SP__,administration)
MOD_ATT:N-ADJ (administration,dietary)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (administration,dosage)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,1)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
COMP:N-N(of) (period,administration)
MOD_ATT:N-ADJ (administration,dietary)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (__NODE__,dosage)
COMP:N-N(of) (dosage,00.2percent)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (00.2percent,expression)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,expression)
MOD_ATT:N-N (expression,week)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD:ADV-N (after,week)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 29

                                                                                                                                                                                               +----------------------COMP:N-N(of)---------------------+                                                             
      +----------------APPOS----------------+                               +------------COMP:N-N(of)-----------+                                                 +---------------------COMP:N-N(of)---------------------+---------COMP:N-N(of)--------+-------COMP:N-N(of)-------+                                  
      +-COMP:N-N(from)-+                    +---------COMP:N-N(with)--------+COMP:N-N(of+                       +-----------COMP:N-N(of)-----------+              +--------COMP:N-N(of)--------+                         |          +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+------COMP:N-N(after)------+      
      |          +MOD_A+        +MOD_ATT:N-A+-COMP:N-N(of)-+                |      +MOD_+              +MOD_ATT:+COMP:N-N(o+           +MOD_ATT:N-A+-COMP:N-N(of)-+-COMP:N-N(with)-+           |                +MOD_ATT:+          |        +MOD_ATT:N+           |       +MOD_AT+      +MOD:+      +MOD_ATT:+      
      |          |     |        |           |              |                |      |    |              |        |          |           |           |              |                |           |                |        |          |        |         |           |       |      |      |    |      |        |      
 In liver from male __SP__ , dietary administration of __NODE__ ( with a dosage of 1 percent and a treatment period of 1 week ) and dietary administration of __NODE__ ( with a dosage of 00.2percent and a treatment period of 1 week ) decrease expression of __SP__ __NODE__ mRNA 1 week after initial treatment .
COMP:N-N(from) (liver,__SP__)
APPOS (liver,administration)
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (administration,dietary)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (administration,dosage)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,1)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
COMP:N-N(of) (period,administration)
MOD_ATT:N-ADJ (administration,dietary)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (__NODE__,dosage)
COMP:N-N(of) (__NODE__,00.2percent)
COMP:N-N(of) (__NODE__,period)
COMP:N-N(of) (00.2percent,expression)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,expression)
MOD_ATT:N-N (expression,week)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD:ADV-N (after,week)
MOD_ATT:N-N (treatment,initial)

Analyse 30

                                                                            +------------COMP:N-N(of)-----------+                                  +----------------------------COMP:N-N(with)---------------------------+---------COMP:N-N(of)--------+-------COMP:N-N(of)-------+                                  
      +-COMP:N-N(from)-+--------APPOS-------+---------COMP:N-N(with)--------+COMP:N-N(of+                       +-----------COMP:N-N(of)-----------+---------COMP:N-N(with)--------+                                     |          +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+------COMP:N-N(after)------+      
      |          +MOD_A+        +MOD_ATT:N-A+-COMP:N-N(of)-+                |      +MOD_+              +MOD_ATT:+COMP:N-N(o+           +MOD_ATT:N-A+-COMP:N-N(of)-+                +COMP:N-N(of+                +MOD_ATT:+          |        +MOD_ATT:N+           |       +MOD_AT+      +MOD:+      +MOD_ATT:+      
      |          |     |        |           |              |                |      |    |              |        |          |           |           |              |                |           |                |        |          |        |         |           |       |      |      |    |      |        |      
 In liver from male __SP__ , dietary administration of __NODE__ ( with a dosage of 1 percent and a treatment period of 1 week ) and dietary administration of __NODE__ ( with a dosage of 00.2percent and a treatment period of 1 week ) decrease expression of __SP__ __NODE__ mRNA 1 week after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
APPOS (__SP__,administration)
MOD_ATT:N-ADJ (administration,dietary)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (administration,dosage)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,1)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
COMP:N-N(of) (period,administration)
MOD_ATT:N-ADJ (administration,dietary)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (administration,dosage)
COMP:N-N(with) (administration,period)
COMP:N-N(of) (dosage,00.2percent)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,expression)
MOD_ATT:N-N (expression,week)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD:ADV-N (after,week)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 31

      +----------------APPOS----------------+                               +------------COMP:N-N(of)-----------+                                                                                                        +---------COMP:N-N(of)--------+-------COMP:N-N(of)-------+                                  
      +-COMP:N-N(from)-+                    +---------COMP:N-N(with)--------+COMP:N-N(of+                       +-----------COMP:N-N(of)-----------+              +--------------------COMP:N-N(with)--------------------+          +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+------COMP:N-N(after)------+      
      |          +MOD_A+        +MOD_ATT:N-A+-COMP:N-N(of)-+                |      +MOD_+              +MOD_ATT:+COMP:N-N(o+           +MOD_ATT:N-A+-COMP:N-N(of)-+-COMP:N-N(with)-+COMP:N-N(of+                +MOD_ATT:+          |        +MOD_ATT:N+           |       +MOD_AT+      +MOD:+      +MOD_ATT:+      
      |          |     |        |           |              |                |      |    |              |        |          |           |           |              |                |           |                |        |          |        |         |           |       |      |      |    |      |        |      
 In liver from male __SP__ , dietary administration of __NODE__ ( with a dosage of 1 percent and a treatment period of 1 week ) and dietary administration of __NODE__ ( with a dosage of 00.2percent and a treatment period of 1 week ) decrease expression of __SP__ __NODE__ mRNA 1 week after initial treatment .
COMP:N-N(from) (liver,__SP__)
APPOS (liver,administration)
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (administration,dietary)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (administration,dosage)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,1)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
COMP:N-N(of) (period,administration)
MOD_ATT:N-ADJ (administration,dietary)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (__NODE__,dosage)
COMP:N-N(with) (__NODE__,period)
COMP:N-N(of) (dosage,00.2percent)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,expression)
MOD_ATT:N-N (expression,week)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD:ADV-N (after,week)
MOD_ATT:N-N (treatment,initial)

Analyse 32

      +----------------APPOS----------------+                               +------------COMP:N-N(of)-----------+                                                                                                        +---------COMP:N-N(of)--------+-------COMP:N-N(of)-------+                                  
      +-COMP:N-N(from)-+                    |                               +COMP:N-N(of+                       +-----------COMP:N-N(of)-----------+                               +-------------COMP:N-N(of)------------+          +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+------COMP:N-N(after)------+      
      |          +MOD_A+        +MOD_ATT:N-A+-COMP:N-N(of)-+-COMP:N-N(with)-+      +MOD_+              +MOD_ATT:+COMP:N-N(o+           +MOD_ATT:N-A+-COMP:N-N(of)-+-COMP:N-N(with)-+COMP:N-N(of+                +MOD_ATT:+          |        +MOD_ATT:N+           |       +MOD_AT+      +MOD:+      +MOD_ATT:+      
      |          |     |        |           |              |                |      |    |              |        |          |           |           |              |                |           |                |        |          |        |         |           |       |      |      |    |      |        |      
 In liver from male __SP__ , dietary administration of __NODE__ ( with a dosage of 1 percent and a treatment period of 1 week ) and dietary administration of __NODE__ ( with a dosage of 00.2percent and a treatment period of 1 week ) decrease expression of __SP__ __NODE__ mRNA 1 week after initial treatment .
COMP:N-N(from) (liver,__SP__)
APPOS (liver,administration)
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (administration,dietary)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (__NODE__,dosage)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,1)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
COMP:N-N(of) (period,administration)
MOD_ATT:N-ADJ (administration,dietary)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (__NODE__,dosage)
COMP:N-N(of) (dosage,00.2percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,expression)
MOD_ATT:N-N (expression,week)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD:ADV-N (after,week)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 33

                                                                                        +-----------------------COMP:N-N(of)-----------------------+                                                                                                                                                                 
      +------------COMP:N-N(from)-----------+                               +------------COMP:N-N(of)-----------+                                  |                                                                                                                                                                 
      |          +-------MOD_ATT:N-ADJ------+                               |           +-----------COMP:N-N(of)-----------+-------------COMP:N-N(of)-------------+                                                      +---------COMP:N-N(of)--------+-------COMP:N-N(of)-------+                                  
      |          |     +----MOD_ATT:N-ADJ---+-------------APPOS-------------+COMP:N-N(of+                       +-----------COMP:N-N(of)-----------+              |                +-------------COMP:N-N(of)------------+          +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+------COMP:N-N(after)------+      
      |          |     |        +MOD_ATT:N-A+-COMP:N-N(of)-+                |      +MOD_+              +MOD_ATT:+COMP:N-N(o+           +MOD_ATT:N-A+-COMP:N-N(of)-+------APPOS-----+COMP:N-N(of+                +MOD_ATT:+          |        +MOD_ATT:N+           |       +MOD_AT+      +MOD:+      +MOD_ATT:+      
      |          |     |        |           |              |                |      |    |              |        |          |           |           |              |                |           |                |        |          |        |         |           |       |      |      |    |      |        |      
 In liver from male __SP__ , dietary administration of __NODE__ ( with a dosage of 1 percent and a treatment period of 1 week ) and dietary administration of __NODE__ ( with a dosage of 00.2percent and a treatment period of 1 week ) decrease expression of __SP__ __NODE__ mRNA 1 week after initial treatment .
COMP:N-N(from) (liver,administration)
MOD_ATT:N-ADJ (administration,male)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-ADJ (administration,dietary)
COMP:N-N(of) (administration,__NODE__)
APPOS (administration,dosage)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,1)
COMP:N-N(of) (percent,week)
COMP:N-N(of) (percent,administration)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
COMP:N-N(of) (period,administration)
COMP:N-N(of) (week,__NODE__)
MOD_ATT:N-ADJ (administration,dietary)
COMP:N-N(of) (administration,__NODE__)
APPOS (__NODE__,dosage)
COMP:N-N(of) (dosage,00.2percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,expression)
MOD_ATT:N-N (expression,week)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD:ADV-N (after,week)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 34

      +------------COMP:N-N(from)-----------+                                                                                                                                                  +----------------------COMP:N-N(of)---------------------+                                                             
      |          +--------MOD_ATT:N-N-------+                               +------------COMP:N-N(of)-----------+          +-------------COMP:N-N(of)-------------+                            |                         +---------COMP:N-N(of)--------+-------COMP:N-N(of)-------+                                  
      |          |     +----MOD_ATT:N-ADJ---+                               +COMP:N-N(of+                       +-----------COMP:N-N(of)-----------+              |                +-------------COMP:N-N(of)------------+          +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+------COMP:N-N(after)------+      
      |          |     |        +MOD_ATT:N-A+-COMP:N-N(of)-+-COMP:N-N(with)-+      +MOD_+              +MOD_ATT:+COMP:N-N(o+           +MOD_ATT:N-A+-COMP:N-N(of)-+------APPOS-----+COMP:N-N(of+                +MOD_ATT:+          |        +MOD_ATT:N+           |       +MOD_AT+      +MOD:+      +MOD_ATT:+      
      |          |     |        |           |              |                |      |    |              |        |          |           |           |              |                |           |                |        |          |        |         |           |       |      |      |    |      |        |      
 In liver from male __SP__ , dietary administration of __NODE__ ( with a dosage of 1 percent and a treatment period of 1 week ) and dietary administration of __NODE__ ( with a dosage of 00.2percent and a treatment period of 1 week ) decrease expression of __SP__ __NODE__ mRNA 1 week after initial treatment .
COMP:N-N(from) (liver,administration)
MOD_ATT:N-N (administration,male)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-ADJ (administration,dietary)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (__NODE__,dosage)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,1)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
COMP:N-N(of) (period,administration)
COMP:N-N(of) (week,__NODE__)
MOD_ATT:N-ADJ (administration,dietary)
COMP:N-N(of) (administration,__NODE__)
APPOS (__NODE__,dosage)
COMP:N-N(of) (dosage,00.2percent)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (00.2percent,expression)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,expression)
MOD_ATT:N-N (expression,week)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD:ADV-N (after,week)
MOD_ATT:N-N (treatment,initial)

Analyse 35

                                                                                        +-----------------------COMP:N-N(of)-----------------------+                                                                                                                                                                 
      +------------COMP:N-N(from)-----------+                               +------------COMP:N-N(of)-----------+                                  |                                                                                                                                                                 
      |          +-------MOD_ATT:N-ADJ------+                               |           +-----------COMP:N-N(of)-----------+                       |                                                                     +---------COMP:N-N(of)--------+-------COMP:N-N(of)-------+                                  
      |          |     +----MOD_ATT:N-ADJ---+                               +COMP:N-N(of+                       +-----------COMP:N-N(of)-----------+                               +-------------COMP:N-N(of)------------+          +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+------COMP:N-N(after)------+      
      |          |     |        +MOD_ATT:N-A+-COMP:N-N(of)-+------APPOS-----+      +MOD_+              +MOD_ATT:+COMP:N-N(o+           +MOD_ATT:N-A+-COMP:N-N(of)-+------APPOS-----+COMP:N-N(of+                +MOD_ATT:+          |        +MOD_ATT:N+           |       +MOD_AT+      +MOD:+      +MOD_ATT:+      
      |          |     |        |           |              |                |      |    |              |        |          |           |           |              |                |           |                |        |          |        |         |           |       |      |      |    |      |        |      
 In liver from male __SP__ , dietary administration of __NODE__ ( with a dosage of 1 percent and a treatment period of 1 week ) and dietary administration of __NODE__ ( with a dosage of 00.2percent and a treatment period of 1 week ) decrease expression of __SP__ __NODE__ mRNA 1 week after initial treatment .
COMP:N-N(from) (liver,administration)
MOD_ATT:N-ADJ (administration,male)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-ADJ (administration,dietary)
COMP:N-N(of) (administration,__NODE__)
APPOS (__NODE__,dosage)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,1)
COMP:N-N(of) (percent,week)
COMP:N-N(of) (percent,administration)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
COMP:N-N(of) (period,administration)
MOD_ATT:N-ADJ (administration,dietary)
COMP:N-N(of) (administration,__NODE__)
APPOS (__NODE__,dosage)
COMP:N-N(of) (dosage,00.2percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,expression)
MOD_ATT:N-N (expression,week)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD:ADV-N (after,week)
MOD_ATT:N-N (treatment,initial)

Analyse 36

                                                                                        +-----------------------COMP:N-N(of)-----------------------+                                                                                                                                                                 
      +------------COMP:N-N(from)-----------+              +--------------------COMP:N-N(of)--------------------+                                  |                                                                                                                                                                 
      |          +--------MOD_ATT:N-N-------+              |                            +-----------COMP:N-N(of)-----------+                       |                                                                     +---------COMP:N-N(of)--------+-------COMP:N-N(of)-------+                                  
      |          |     +----MOD_ATT:N-ADJ---+              +--------COMP:N-N(of)--------+                       +-----------COMP:N-N(of)-----------+-------------APPOS-------------+-------------COMP:N-N(of)------------+          +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+------COMP:N-N(after)------+      
      |          |     |        +MOD_ATT:N-A+-COMP:N-N(of)-+-COMP:N-N(with)-+      +MOD_+              +MOD_ATT:+COMP:N-N(o+           +MOD_ATT:N-A+-COMP:N-N(of)-+                +COMP:N-N(of+                +MOD_ATT:+          |        +MOD_ATT:N+           |       +MOD_AT+      +MOD:+      +MOD_ATT:+      
      |          |     |        |           |              |                |      |    |              |        |          |           |           |              |                |           |                |        |          |        |         |           |       |      |      |    |      |        |      
 In liver from male __SP__ , dietary administration of __NODE__ ( with a dosage of 1 percent and a treatment period of 1 week ) and dietary administration of __NODE__ ( with a dosage of 00.2percent and a treatment period of 1 week ) decrease expression of __SP__ __NODE__ mRNA 1 week after initial treatment .
COMP:N-N(from) (liver,administration)
MOD_ATT:N-N (administration,male)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-ADJ (administration,dietary)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (__NODE__,dosage)
COMP:N-N(of) (__NODE__,percent)
COMP:N-N(of) (__NODE__,period)
MOD_ATT:N-ADJ (percent,1)
COMP:N-N(of) (percent,week)
COMP:N-N(of) (percent,administration)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
COMP:N-N(of) (period,administration)
MOD_ATT:N-ADJ (administration,dietary)
COMP:N-N(of) (administration,__NODE__)
APPOS (administration,dosage)
COMP:N-N(of) (dosage,00.2percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,expression)
MOD_ATT:N-N (expression,week)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD:ADV-N (after,week)
MOD_ATT:N-N (treatment,initial)

Analyse 37

      +------------COMP:N-N(from)-----------+                                                                                                                                                                                                                                                                        
      |          +--------MOD_ATT:N-N-------+                               +------------COMP:N-N(of)-----------+                                                                                                        +---------COMP:N-N(of)--------+-------COMP:N-N(of)-------+                                  
      |          |     +----MOD_ATT:N-ADJ---+                               +COMP:N-N(of+                       +-----------COMP:N-N(of)-----------+-------------APPOS-------------+-------------COMP:N-N(of)------------+          +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+------COMP:N-N(after)------+      
      |          |     |        +MOD_ATT:N-A+-COMP:N-N(of)-+-COMP:N-N(with)-+      +MOD_+              +MOD_ATT:+COMP:N-N(o+           +MOD_ATT:N-A+-COMP:N-N(of)-+                +COMP:N-N(of+                +MOD_ATT:+          |        +MOD_ATT:N+           |       +MOD_AT+      +MOD:+      +MOD_ATT:+      
      |          |     |        |           |              |                |      |    |              |        |          |           |           |              |                |           |                |        |          |        |         |           |       |      |      |    |      |        |      
 In liver from male __SP__ , dietary administration of __NODE__ ( with a dosage of 1 percent and a treatment period of 1 week ) and dietary administration of __NODE__ ( with a dosage of 00.2percent and a treatment period of 1 week ) decrease expression of __SP__ __NODE__ mRNA 1 week after initial treatment .
COMP:N-N(from) (liver,administration)
MOD_ATT:N-N (administration,male)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-ADJ (administration,dietary)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (__NODE__,dosage)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,1)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
COMP:N-N(of) (period,administration)
MOD_ATT:N-ADJ (administration,dietary)
COMP:N-N(of) (administration,__NODE__)
APPOS (administration,dosage)
COMP:N-N(of) (dosage,00.2percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,expression)
MOD_ATT:N-N (expression,week)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD:ADV-N (after,week)
MOD_ATT:N-N (treatment,initial)

Analyse 38

                                                                                        +-----------------------COMP:N-N(of)-----------------------+                                                                                                                                                                 
                                                                            +------------COMP:N-N(of)-----------+          +---------------------COMP:N-N(with)--------------------+           +----------------------COMP:N-N(of)---------------------+                                                             
      +----------------APPOS----------------+                               |           +-----------COMP:N-N(of)-----------+-------------COMP:N-N(of)-------------+                |           |                         +---------COMP:N-N(of)--------+-------COMP:N-N(of)-------+                                  
      +-COMP:N-N(from)-+                    +-------------APPOS-------------+COMP:N-N(of+                       +-----------COMP:N-N(of)-----------+---------COMP:N-N(with)--------+-------------COMP:N-N(of)------------+          +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+------COMP:N-N(after)------+      
      |          +MOD_A+        +MOD_ATT:N-A+-COMP:N-N(of)-+                |      +MOD_+              +MOD_ATT:+COMP:N-N(o+           +MOD_ATT:N-A+-COMP:N-N(of)-+                +COMP:N-N(of+                +MOD_ATT:+          |        +MOD_ATT:N+           |       +MOD_AT+      +MOD:+      +MOD_ATT:+      
      |          |     |        |           |              |                |      |    |              |        |          |           |           |              |                |           |                |        |          |        |         |           |       |      |      |    |      |        |      
 In liver from male __SP__ , dietary administration of __NODE__ ( with a dosage of 1 percent and a treatment period of 1 week ) and dietary administration of __NODE__ ( with a dosage of 00.2percent and a treatment period of 1 week ) decrease expression of __SP__ __NODE__ mRNA 1 week after initial treatment .
COMP:N-N(from) (liver,__SP__)
APPOS (liver,administration)
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (administration,dietary)
COMP:N-N(of) (administration,__NODE__)
APPOS (administration,dosage)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,1)
COMP:N-N(of) (percent,week)
COMP:N-N(of) (percent,administration)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
COMP:N-N(of) (period,administration)
COMP:N-N(of) (week,__NODE__)
COMP:N-N(with) (week,dosage)
MOD_ATT:N-ADJ (administration,dietary)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (administration,dosage)
COMP:N-N(of) (dosage,00.2percent)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (00.2percent,expression)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,expression)
MOD_ATT:N-N (expression,week)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD:ADV-N (after,week)
MOD_ATT:N-N (treatment,initial)

Analyse 39

                                                                                                                           +----------------------------------------COMP:N-N(with)---------------------------------------+                                                                                           
                                                                                        +-----------------------COMP:N-N(of)-----------------------+----------------------------COMP:N-N(with)---------------------------+                                                                                           
                                                                            +------------COMP:N-N(of)-----------+          +---------------------COMP:N-N(with)--------------------+                                     |                                                                                           
                                                                            |           +-----------COMP:N-N(of)-----------+-------------COMP:N-N(of)-------------+                |                                     +---------COMP:N-N(of)--------+-------COMP:N-N(of)-------+                                  
      +-COMP:N-N(from)-+--------APPOS-------+-------------APPOS-------------+COMP:N-N(of+                       +-----------COMP:N-N(of)-----------+---------COMP:N-N(with)--------+                                     |          +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+------COMP:N-N(after)------+      
      |          +MOD_A+        +MOD_ATT:N-A+-COMP:N-N(of)-+                |      +MOD_+              +MOD_ATT:+COMP:N-N(o+           +MOD_ATT:N-A+-COMP:N-N(of)-+                +COMP:N-N(of+                +MOD_ATT:+          |        +MOD_ATT:N+           |       +MOD_AT+      +MOD:+      +MOD_ATT:+      
      |          |     |        |           |              |                |      |    |              |        |          |           |           |              |                |           |                |        |          |        |         |           |       |      |      |    |      |        |      
 In liver from male __SP__ , dietary administration of __NODE__ ( with a dosage of 1 percent and a treatment period of 1 week ) and dietary administration of __NODE__ ( with a dosage of 00.2percent and a treatment period of 1 week ) decrease expression of __SP__ __NODE__ mRNA 1 week after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
APPOS (__SP__,administration)
MOD_ATT:N-ADJ (administration,dietary)
COMP:N-N(of) (administration,__NODE__)
APPOS (administration,dosage)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,1)
COMP:N-N(of) (percent,week)
COMP:N-N(of) (percent,administration)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
COMP:N-N(of) (period,administration)
COMP:N-N(of) (week,__NODE__)
COMP:N-N(with) (week,dosage)
COMP:N-N(with) (week,period)
MOD_ATT:N-ADJ (administration,dietary)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (administration,dosage)
COMP:N-N(with) (administration,period)
COMP:N-N(of) (dosage,00.2percent)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,expression)
MOD_ATT:N-N (expression,week)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD:ADV-N (after,week)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 40

      +------------COMP:N-N(from)-----------+                                                                              +---------------------COMP:N-N(with)--------------------+           +----------------------COMP:N-N(of)---------------------+                                                             
      |          +-------MOD_ATT:N-ADJ------+                               +------------COMP:N-N(of)-----------+          +-------------COMP:N-N(of)-------------+                |           |                         +---------COMP:N-N(of)--------+-------COMP:N-N(of)-------+                                  
      |          |     +----MOD_ATT:N-ADJ---+-------------APPOS-------------+COMP:N-N(of+-----------COMP:N-N(of)-----------+                       +---------COMP:N-N(with)--------+-------------COMP:N-N(of)------------+          +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+------COMP:N-N(after)------+      
      |          |     |        +MOD_ATT:N-A+-COMP:N-N(of)-+                |      +MOD_+              +MOD_ATT:+COMP:N-N(o+           +MOD_ATT:N-A+-COMP:N-N(of)-+                +COMP:N-N(of+                +MOD_ATT:+          |        +MOD_ATT:N+           |       +MOD_AT+      +MOD:+      +MOD_ATT:+      
      |          |     |        |           |              |                |      |    |              |        |          |           |           |              |                |           |                |        |          |        |         |           |       |      |      |    |      |        |      
 In liver from male __SP__ , dietary administration of __NODE__ ( with a dosage of 1 percent and a treatment period of 1 week ) and dietary administration of __NODE__ ( with a dosage of 00.2percent and a treatment period of 1 week ) decrease expression of __SP__ __NODE__ mRNA 1 week after initial treatment .
COMP:N-N(from) (liver,administration)
MOD_ATT:N-ADJ (administration,male)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-ADJ (administration,dietary)
COMP:N-N(of) (administration,__NODE__)
APPOS (administration,dosage)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,1)
COMP:N-N(of) (percent,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
COMP:N-N(of) (week,__NODE__)
COMP:N-N(with) (week,dosage)
MOD_ATT:N-ADJ (administration,dietary)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (administration,dosage)
COMP:N-N(of) (dosage,00.2percent)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (00.2percent,expression)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,expression)
MOD_ATT:N-N (expression,week)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD:ADV-N (after,week)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 41

                                                                                                                           +----------------------------------------COMP:N-N(with)---------------------------------------+                                                                                           
                                                                                        +-----------------------COMP:N-N(of)-----------------------+----------------------------COMP:N-N(with)---------------------------+                                                                                           
      +------------COMP:N-N(from)-----------+                                           |                                  +---------------------COMP:N-N(with)--------------------+                                     |                                                                                           
      |          +-------MOD_ATT:N-ADJ------+                                           +-----------COMP:N-N(of)-----------+-------------COMP:N-N(of)-------------+                |                                     +---------COMP:N-N(of)--------+-------COMP:N-N(of)-------+                                  
      |          |     +----MOD_ATT:N-ADJ---+                               +COMP:N-N(of+                       +-----------COMP:N-N(of)-----------+---------COMP:N-N(with)--------+                                     |          +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+------COMP:N-N(after)------+      
      |          |     |        +MOD_ATT:N-A+-COMP:N-N(of)-+------APPOS-----+      +MOD_+              +MOD_ATT:+COMP:N-N(o+           +MOD_ATT:N-A+-COMP:N-N(of)-+                +COMP:N-N(of+                +MOD_ATT:+          |        +MOD_ATT:N+           |       +MOD_AT+      +MOD:+      +MOD_ATT:+      
      |          |     |        |           |              |                |      |    |              |        |          |           |           |              |                |           |                |        |          |        |         |           |       |      |      |    |      |        |      
 In liver from male __SP__ , dietary administration of __NODE__ ( with a dosage of 1 percent and a treatment period of 1 week ) and dietary administration of __NODE__ ( with a dosage of 00.2percent and a treatment period of 1 week ) decrease expression of __SP__ __NODE__ mRNA 1 week after initial treatment .
COMP:N-N(from) (liver,administration)
MOD_ATT:N-ADJ (administration,male)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-ADJ (administration,dietary)
COMP:N-N(of) (administration,__NODE__)
APPOS (__NODE__,dosage)
COMP:N-N(of) (dosage,percent)
MOD_ATT:N-ADJ (percent,1)
COMP:N-N(of) (percent,week)
COMP:N-N(of) (percent,administration)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
COMP:N-N(of) (period,administration)
COMP:N-N(of) (week,__NODE__)
COMP:N-N(with) (week,dosage)
COMP:N-N(with) (week,period)
MOD_ATT:N-ADJ (administration,dietary)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (administration,dosage)
COMP:N-N(with) (administration,period)
COMP:N-N(of) (dosage,00.2percent)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,expression)
MOD_ATT:N-N (expression,week)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD:ADV-N (after,week)
MOD_ATT:N-N (treatment,initial)

Analyse 42

                                                                                        +-----------------------COMP:N-N(of)-----------------------+                                                                                                                                                                 
                                                                            +------------COMP:N-N(of)-----------+                                  |                                           +----------------------COMP:N-N(of)---------------------+                                                             
      +----------------APPOS----------------+                               |           +-----------COMP:N-N(of)-----------+                       |                                           |                         +---------COMP:N-N(of)--------+-------COMP:N-N(of)-------+                                  
      +-COMP:N-N(from)-+                    |                               +COMP:N-N(of+                       +-----------COMP:N-N(of)-----------+---------COMP:N-N(with)--------+-------------COMP:N-N(of)------------+          +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+------COMP:N-N(after)------+      
      |          +MOD_A+        +MOD_ATT:N-A+-COMP:N-N(of)-+------APPOS-----+      +MOD_+              +MOD_ATT:+COMP:N-N(o+           +MOD_ATT:N-A+-COMP:N-N(of)-+                +COMP:N-N(of+                +MOD_ATT:+          |        +MOD_ATT:N+           |       +MOD_AT+      +MOD:+      +MOD_ATT:+      
      |          |     |        |           |              |                |      |    |              |        |          |           |           |              |                |           |                |        |          |        |         |           |       |      |      |    |      |        |      
 In liver from male __SP__ , dietary administration of __NODE__ ( with a dosage of 1 percent and a treatment period of 1 week ) and dietary administration of __NODE__ ( with a dosage of 00.2percent and a treatment period of 1 week ) decrease expression of __SP__ __NODE__ mRNA 1 week after initial treatment .
COMP:N-N(from) (liver,__SP__)
APPOS (liver,administration)
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (administration,dietary)
COMP:N-N(of) (administration,__NODE__)
APPOS (__NODE__,dosage)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,1)
COMP:N-N(of) (percent,week)
COMP:N-N(of) (percent,administration)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
COMP:N-N(of) (period,administration)
MOD_ATT:N-ADJ (administration,dietary)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (administration,dosage)
COMP:N-N(of) (dosage,00.2percent)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (00.2percent,expression)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,expression)
MOD_ATT:N-N (expression,week)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD:ADV-N (after,week)
MOD_ATT:N-N (treatment,initial)

Analyse 43

      +------------COMP:N-N(from)-----------+                                           +-----------------------COMP:N-N(of)-----------------------+                                                                                                                                                                 
      |          +--------MOD_ATT:N-N-------+                                           +-----------COMP:N-N(of)-----------+-------------COMP:N-N(of)-------------+                                                      +---------COMP:N-N(of)--------+-------COMP:N-N(of)-------+                                  
      |          |     +----MOD_ATT:N-ADJ---+                               +COMP:N-N(of+                       +-----------COMP:N-N(of)-----------+              |                +-------------COMP:N-N(of)------------+          +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+------COMP:N-N(after)------+      
      |          |     |        +MOD_ATT:N-A+-COMP:N-N(of)-+-COMP:N-N(with)-+      +MOD_+              +MOD_ATT:+COMP:N-N(o+           +MOD_ATT:N-A+-COMP:N-N(of)-+-COMP:N-N(with)-+COMP:N-N(of+                +MOD_ATT:+          |        +MOD_ATT:N+           |       +MOD_AT+      +MOD:+      +MOD_ATT:+      
      |          |     |        |           |              |                |      |    |              |        |          |           |           |              |                |           |                |        |          |        |         |           |       |      |      |    |      |        |      
 In liver from male __SP__ , dietary administration of __NODE__ ( with a dosage of 1 percent and a treatment period of 1 week ) and dietary administration of __NODE__ ( with a dosage of 00.2percent and a treatment period of 1 week ) decrease expression of __SP__ __NODE__ mRNA 1 week after initial treatment .
COMP:N-N(from) (liver,administration)
MOD_ATT:N-N (administration,male)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-ADJ (administration,dietary)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (__NODE__,dosage)
COMP:N-N(of) (dosage,percent)
MOD_ATT:N-ADJ (percent,1)
COMP:N-N(of) (percent,week)
COMP:N-N(of) (percent,administration)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
COMP:N-N(of) (period,administration)
COMP:N-N(of) (week,__NODE__)
MOD_ATT:N-ADJ (administration,dietary)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (__NODE__,dosage)
COMP:N-N(of) (dosage,00.2percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,expression)
MOD_ATT:N-N (expression,week)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD:ADV-N (after,week)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 44

                                                                                        +-----------------------COMP:N-N(of)-----------------------+                                                                                                                                                                 
      +------------COMP:N-N(from)-----------+              +--------------------COMP:N-N(of)--------------------+          +---------------------COMP:N-N(with)--------------------+           +----------------------COMP:N-N(of)---------------------+                                                             
      |          +--------MOD_ATT:N-N-------+              |                            +-----------COMP:N-N(of)-----------+-------------COMP:N-N(of)-------------+                |           |                         +---------COMP:N-N(of)--------+-------COMP:N-N(of)-------+                                  
      |          |     +----MOD_ATT:N-ADJ---+              +--------COMP:N-N(of)--------+                       +-----------COMP:N-N(of)-----------+---------COMP:N-N(with)--------+           |                         |          +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+------COMP:N-N(after)------+      
      |          |     |        +MOD_ATT:N-A+-COMP:N-N(of)-+-COMP:N-N(with)-+      +MOD_+              +MOD_ATT:+COMP:N-N(o+           +MOD_ATT:N-A+-COMP:N-N(of)-+                +COMP:N-N(of+                +MOD_ATT:+          |        +MOD_ATT:N+           |       +MOD_AT+      +MOD:+      +MOD_ATT:+      
      |          |     |        |           |              |                |      |    |              |        |          |           |           |              |                |           |                |        |          |        |         |           |       |      |      |    |      |        |      
 In liver from male __SP__ , dietary administration of __NODE__ ( with a dosage of 1 percent and a treatment period of 1 week ) and dietary administration of __NODE__ ( with a dosage of 00.2percent and a treatment period of 1 week ) decrease expression of __SP__ __NODE__ mRNA 1 week after initial treatment .
COMP:N-N(from) (liver,administration)
MOD_ATT:N-N (administration,male)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-ADJ (administration,dietary)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (__NODE__,dosage)
COMP:N-N(of) (__NODE__,percent)
COMP:N-N(of) (__NODE__,period)
MOD_ATT:N-ADJ (percent,1)
COMP:N-N(of) (percent,week)
COMP:N-N(of) (percent,administration)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
COMP:N-N(of) (period,administration)
COMP:N-N(of) (week,__NODE__)
COMP:N-N(with) (week,dosage)
MOD_ATT:N-ADJ (administration,dietary)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (administration,dosage)
COMP:N-N(of) (dosage,00.2percent)
COMP:N-N(of) (00.2percent,expression)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,expression)
MOD_ATT:N-N (expression,week)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD:ADV-N (after,week)
MOD_ATT:N-N (treatment,initial)

Analyse 45

                                                                                        +-----------------------COMP:N-N(of)-----------------------+                                                                                                                                                                 
                                                                            +------------COMP:N-N(of)-----------+                                  |                                                                                                                                                                 
      +----------------APPOS----------------+                               |           +-----------COMP:N-N(of)-----------+                       +----------------------------COMP:N-N(with)---------------------------+---------COMP:N-N(of)--------+-------COMP:N-N(of)-------+                                  
      +-COMP:N-N(from)-+                    |                               +COMP:N-N(of+                       +-----------COMP:N-N(of)-----------+---------COMP:N-N(with)--------+                                     |          +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+------COMP:N-N(after)------+      
      |          +MOD_A+        +MOD_ATT:N-A+-COMP:N-N(of)-+------APPOS-----+      +MOD_+              +MOD_ATT:+COMP:N-N(o+           +MOD_ATT:N-A+-COMP:N-N(of)-+                +COMP:N-N(of+                +MOD_ATT:+          |        +MOD_ATT:N+           |       +MOD_AT+      +MOD:+      +MOD_ATT:+      
      |          |     |        |           |              |                |      |    |              |        |          |           |           |              |                |           |                |        |          |        |         |           |       |      |      |    |      |        |      
 In liver from male __SP__ , dietary administration of __NODE__ ( with a dosage of 1 percent and a treatment period of 1 week ) and dietary administration of __NODE__ ( with a dosage of 00.2percent and a treatment period of 1 week ) decrease expression of __SP__ __NODE__ mRNA 1 week after initial treatment .
COMP:N-N(from) (liver,__SP__)
APPOS (liver,administration)
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (administration,dietary)
COMP:N-N(of) (administration,__NODE__)
APPOS (__NODE__,dosage)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,1)
COMP:N-N(of) (percent,week)
COMP:N-N(of) (percent,administration)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
COMP:N-N(of) (period,administration)
MOD_ATT:N-ADJ (administration,dietary)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (administration,dosage)
COMP:N-N(with) (administration,period)
COMP:N-N(of) (dosage,00.2percent)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,expression)
MOD_ATT:N-N (expression,week)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD:ADV-N (after,week)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 46

                                                                                        +-----------------------COMP:N-N(of)-----------------------+                                                                                                                                                                 
                                                                            +------------COMP:N-N(of)-----------+                                  |                                                                                                                                                                 
                                                                            |           +-----------COMP:N-N(of)-----------+                       |                                                                     +---------COMP:N-N(of)--------+-------COMP:N-N(of)-------+                                  
      +-COMP:N-N(from)-+--------APPOS-------+                               +COMP:N-N(of+                       +-----------COMP:N-N(of)-----------+---------COMP:N-N(with)--------+-------------COMP:N-N(of)------------+          +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+------COMP:N-N(after)------+      
      |          +MOD_A+        +MOD_ATT:N-A+-COMP:N-N(of)-+------APPOS-----+      +MOD_+              +MOD_ATT:+COMP:N-N(o+           +MOD_ATT:N-A+-COMP:N-N(of)-+                +COMP:N-N(of+                +MOD_ATT:+          |        +MOD_ATT:N+           |       +MOD_AT+      +MOD:+      +MOD_ATT:+      
      |          |     |        |           |              |                |      |    |              |        |          |           |           |              |                |           |                |        |          |        |         |           |       |      |      |    |      |        |      
 In liver from male __SP__ , dietary administration of __NODE__ ( with a dosage of 1 percent and a treatment period of 1 week ) and dietary administration of __NODE__ ( with a dosage of 00.2percent and a treatment period of 1 week ) decrease expression of __SP__ __NODE__ mRNA 1 week after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
APPOS (__SP__,administration)
MOD_ATT:N-ADJ (administration,dietary)
COMP:N-N(of) (administration,__NODE__)
APPOS (__NODE__,dosage)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,1)
COMP:N-N(of) (percent,week)
COMP:N-N(of) (percent,administration)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
COMP:N-N(of) (period,administration)
MOD_ATT:N-ADJ (administration,dietary)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (administration,dosage)
COMP:N-N(of) (dosage,00.2percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,expression)
MOD_ATT:N-N (expression,week)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD:ADV-N (after,week)
MOD_ATT:N-N (treatment,initial)

Analyse 47

      +----------------APPOS----------------+              +-------------------COMP:N-N(with)-------------------+          +-------------COMP:N-N(of)-------------+                                                      +---------COMP:N-N(of)--------+-------COMP:N-N(of)-------+                                  
      +-COMP:N-N(from)-+                    |              |                +COMP:N-N(of+                       +-----------COMP:N-N(of)-----------+              |                +-------------COMP:N-N(of)------------+          +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+------COMP:N-N(after)------+      
      |          +MOD_A+        +MOD_ATT:N-A+-COMP:N-N(of)-+-COMP:N-N(with)-+      +MOD_+              +MOD_ATT:+COMP:N-N(o+           +MOD_ATT:N-A+-COMP:N-N(of)-+------APPOS-----+COMP:N-N(of+                +MOD_ATT:+          |        +MOD_ATT:N+           |       +MOD_AT+      +MOD:+      +MOD_ATT:+      
      |          |     |        |           |              |                |      |    |              |        |          |           |           |              |                |           |                |        |          |        |         |           |       |      |      |    |      |        |      
 In liver from male __SP__ , dietary administration of __NODE__ ( with a dosage of 1 percent and a treatment period of 1 week ) and dietary administration of __NODE__ ( with a dosage of 00.2percent and a treatment period of 1 week ) decrease expression of __SP__ __NODE__ mRNA 1 week after initial treatment .
COMP:N-N(from) (liver,__SP__)
APPOS (liver,administration)
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (administration,dietary)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (__NODE__,dosage)
COMP:N-N(with) (__NODE__,period)
COMP:N-N(of) (dosage,percent)
MOD_ATT:N-ADJ (percent,1)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
COMP:N-N(of) (period,administration)
COMP:N-N(of) (week,__NODE__)
MOD_ATT:N-ADJ (administration,dietary)
COMP:N-N(of) (administration,__NODE__)
APPOS (__NODE__,dosage)
COMP:N-N(of) (dosage,00.2percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,expression)
MOD_ATT:N-N (expression,week)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD:ADV-N (after,week)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 48

      +----------------APPOS----------------+                               +------------COMP:N-N(of)-----------+          +-------------COMP:N-N(of)-------------+                                                      +---------COMP:N-N(of)--------+-------COMP:N-N(of)-------+                                  
      +-COMP:N-N(from)-+                    +-------------APPOS-------------+COMP:N-N(of+                       +-----------COMP:N-N(of)-----------+              |                +-------------COMP:N-N(of)------------+          +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+------COMP:N-N(after)------+      
      |          +MOD_A+        +MOD_ATT:N-A+-COMP:N-N(of)-+                |      +MOD_+              +MOD_ATT:+COMP:N-N(o+           +MOD_ATT:N-A+-COMP:N-N(of)-+-COMP:N-N(with)-+COMP:N-N(of+                +MOD_ATT:+          |        +MOD_ATT:N+           |       +MOD_AT+      +MOD:+      +MOD_ATT:+      
      |          |     |        |           |              |                |      |    |              |        |          |           |           |              |                |           |                |        |          |        |         |           |       |      |      |    |      |        |      
 In liver from male __SP__ , dietary administration of __NODE__ ( with a dosage of 1 percent and a treatment period of 1 week ) and dietary administration of __NODE__ ( with a dosage of 00.2percent and a treatment period of 1 week ) decrease expression of __SP__ __NODE__ mRNA 1 week after initial treatment .
COMP:N-N(from) (liver,__SP__)
APPOS (liver,administration)
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (administration,dietary)
COMP:N-N(of) (administration,__NODE__)
APPOS (administration,dosage)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,1)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
COMP:N-N(of) (period,administration)
COMP:N-N(of) (week,__NODE__)
MOD_ATT:N-ADJ (administration,dietary)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (__NODE__,dosage)
COMP:N-N(of) (dosage,00.2percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,expression)
MOD_ATT:N-N (expression,week)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD:ADV-N (after,week)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 49

                                                                                                                           +---------------------COMP:N-N(with)--------------------+                                                                                                                                 
      +----------------APPOS----------------+                               +------------COMP:N-N(of)-----------+          +-------------COMP:N-N(of)-------------+                |                                     +---------COMP:N-N(of)--------+-------COMP:N-N(of)-------+                                  
      +-COMP:N-N(from)-+                    +-------------APPOS-------------+COMP:N-N(of+                       +-----------COMP:N-N(of)-----------+---------COMP:N-N(with)--------+-------------COMP:N-N(of)------------+          +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+------COMP:N-N(after)------+      
      |          +MOD_A+        +MOD_ATT:N-A+-COMP:N-N(of)-+                |      +MOD_+              +MOD_ATT:+COMP:N-N(o+           +MOD_ATT:N-A+-COMP:N-N(of)-+                +COMP:N-N(of+                +MOD_ATT:+          |        +MOD_ATT:N+           |       +MOD_AT+      +MOD:+      +MOD_ATT:+      
      |          |     |        |           |              |                |      |    |              |        |          |           |           |              |                |           |                |        |          |        |         |           |       |      |      |    |      |        |      
 In liver from male __SP__ , dietary administration of __NODE__ ( with a dosage of 1 percent and a treatment period of 1 week ) and dietary administration of __NODE__ ( with a dosage of 00.2percent and a treatment period of 1 week ) decrease expression of __SP__ __NODE__ mRNA 1 week after initial treatment .
COMP:N-N(from) (liver,__SP__)
APPOS (liver,administration)
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (administration,dietary)
COMP:N-N(of) (administration,__NODE__)
APPOS (administration,dosage)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,1)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
COMP:N-N(of) (period,administration)
COMP:N-N(of) (week,__NODE__)
COMP:N-N(with) (week,dosage)
MOD_ATT:N-ADJ (administration,dietary)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (administration,dosage)
COMP:N-N(of) (dosage,00.2percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,expression)
MOD_ATT:N-N (expression,week)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD:ADV-N (after,week)
MOD_ATT:N-N (treatment,initial)

Analyse 50

      +------------COMP:N-N(from)-----------+                                           +-----------------------COMP:N-N(of)-----------------------+                                                                                                                                                                 
      |          +-------MOD_ATT:N-ADJ------+                                           +-----------COMP:N-N(of)-----------+                       |                                                                     +---------COMP:N-N(of)--------+-------COMP:N-N(of)-------+                                  
      |          |     +----MOD_ATT:N-ADJ---+              +--------COMP:N-N(of)--------+                       +-----------COMP:N-N(of)-----------+-------------APPOS-------------+-------------COMP:N-N(of)------------+          +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+------COMP:N-N(after)------+      
      |          |     |        +MOD_ATT:N-A+-COMP:N-N(of)-+-COMP:N-N(with)-+      +MOD_+              +MOD_ATT:+COMP:N-N(o+           +MOD_ATT:N-A+-COMP:N-N(of)-+                +COMP:N-N(of+                +MOD_ATT:+          |        +MOD_ATT:N+           |       +MOD_AT+      +MOD:+      +MOD_ATT:+      
      |          |     |        |           |              |                |      |    |              |        |          |           |           |              |                |           |                |        |          |        |         |           |       |      |      |    |      |        |      
 In liver from male __SP__ , dietary administration of __NODE__ ( with a dosage of 1 percent and a treatment period of 1 week ) and dietary administration of __NODE__ ( with a dosage of 00.2percent and a treatment period of 1 week ) decrease expression of __SP__ __NODE__ mRNA 1 week after initial treatment .
COMP:N-N(from) (liver,administration)
MOD_ATT:N-ADJ (administration,male)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-ADJ (administration,dietary)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (__NODE__,dosage)
COMP:N-N(of) (__NODE__,percent)
MOD_ATT:N-ADJ (percent,1)
COMP:N-N(of) (percent,week)
COMP:N-N(of) (percent,administration)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
COMP:N-N(of) (period,administration)
MOD_ATT:N-ADJ (administration,dietary)
COMP:N-N(of) (administration,__NODE__)
APPOS (administration,dosage)
COMP:N-N(of) (dosage,00.2percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,expression)
MOD_ATT:N-N (expression,week)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD:ADV-N (after,week)
MOD_ATT:N-N (treatment,initial)

Analyse 51

                                                                                                                                                                                               +----------------------COMP:N-N(of)---------------------+                                                             
      +----------------APPOS----------------+                               +------------COMP:N-N(of)-----------+                                                 +---------------------COMP:N-N(of)---------------------+---------COMP:N-N(of)--------+-------COMP:N-N(of)-------+                                  
      +-COMP:N-N(from)-+                    +-------------APPOS-------------+COMP:N-N(of+                       +-----------COMP:N-N(of)-----------+              +--------COMP:N-N(of)--------+                         |          +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+------COMP:N-N(after)------+      
      |          +MOD_A+        +MOD_ATT:N-A+-COMP:N-N(of)-+                |      +MOD_+              +MOD_ATT:+COMP:N-N(o+           +MOD_ATT:N-A+-COMP:N-N(of)-+-COMP:N-N(with)-+           |                +MOD_ATT:+          |        +MOD_ATT:N+           |       +MOD_AT+      +MOD:+      +MOD_ATT:+      
      |          |     |        |           |              |                |      |    |              |        |          |           |           |              |                |           |                |        |          |        |         |           |       |      |      |    |      |        |      
 In liver from male __SP__ , dietary administration of __NODE__ ( with a dosage of 1 percent and a treatment period of 1 week ) and dietary administration of __NODE__ ( with a dosage of 00.2percent and a treatment period of 1 week ) decrease expression of __SP__ __NODE__ mRNA 1 week after initial treatment .
COMP:N-N(from) (liver,__SP__)
APPOS (liver,administration)
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (administration,dietary)
COMP:N-N(of) (administration,__NODE__)
APPOS (administration,dosage)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,1)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
COMP:N-N(of) (period,administration)
MOD_ATT:N-ADJ (administration,dietary)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (__NODE__,dosage)
COMP:N-N(of) (__NODE__,00.2percent)
COMP:N-N(of) (__NODE__,period)
COMP:N-N(of) (00.2percent,expression)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,expression)
MOD_ATT:N-N (expression,week)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD:ADV-N (after,week)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 52

                                                                                                                                                                                               +----------------------COMP:N-N(of)---------------------+                                                             
                                                                            +------------COMP:N-N(of)-----------+                                                                              |                         +---------COMP:N-N(of)--------+-------COMP:N-N(of)-------+                                  
      +-COMP:N-N(from)-+--------APPOS-------+-------------APPOS-------------+COMP:N-N(of+                       +-----------COMP:N-N(of)-----------+---------COMP:N-N(with)--------+-------------COMP:N-N(of)------------+          +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+------COMP:N-N(after)------+      
      |          +MOD_A+        +MOD_ATT:N-A+-COMP:N-N(of)-+                |      +MOD_+              +MOD_ATT:+COMP:N-N(o+           +MOD_ATT:N-A+-COMP:N-N(of)-+                +COMP:N-N(of+                +MOD_ATT:+          |        +MOD_ATT:N+           |       +MOD_AT+      +MOD:+      +MOD_ATT:+      
      |          |     |        |           |              |                |      |    |              |        |          |           |           |              |                |           |                |        |          |        |         |           |       |      |      |    |      |        |      
 In liver from male __SP__ , dietary administration of __NODE__ ( with a dosage of 1 percent and a treatment period of 1 week ) and dietary administration of __NODE__ ( with a dosage of 00.2percent and a treatment period of 1 week ) decrease expression of __SP__ __NODE__ mRNA 1 week after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
APPOS (__SP__,administration)
MOD_ATT:N-ADJ (administration,dietary)
COMP:N-N(of) (administration,__NODE__)
APPOS (administration,dosage)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,1)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
COMP:N-N(of) (period,administration)
MOD_ATT:N-ADJ (administration,dietary)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (administration,dosage)
COMP:N-N(of) (dosage,00.2percent)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (00.2percent,expression)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,expression)
MOD_ATT:N-N (expression,week)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD:ADV-N (after,week)
MOD_ATT:N-N (treatment,initial)

Analyse 53

      +----------------APPOS----------------+                               +------------COMP:N-N(of)-----------+                                                                                                        +---------COMP:N-N(of)--------+-------COMP:N-N(of)-------+                                  
      +-COMP:N-N(from)-+                    |                               +COMP:N-N(of+                       +-----------COMP:N-N(of)-----------+                               +-------------COMP:N-N(of)------------+          +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+------COMP:N-N(after)------+      
      |          +MOD_A+        +MOD_ATT:N-A+-COMP:N-N(of)-+------APPOS-----+      +MOD_+              +MOD_ATT:+COMP:N-N(o+           +MOD_ATT:N-A+-COMP:N-N(of)-+-COMP:N-N(with)-+COMP:N-N(of+                +MOD_ATT:+          |        +MOD_ATT:N+           |       +MOD_AT+      +MOD:+      +MOD_ATT:+      
      |          |     |        |           |              |                |      |    |              |        |          |           |           |              |                |           |                |        |          |        |         |           |       |      |      |    |      |        |      
 In liver from male __SP__ , dietary administration of __NODE__ ( with a dosage of 1 percent and a treatment period of 1 week ) and dietary administration of __NODE__ ( with a dosage of 00.2percent and a treatment period of 1 week ) decrease expression of __SP__ __NODE__ mRNA 1 week after initial treatment .
COMP:N-N(from) (liver,__SP__)
APPOS (liver,administration)
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (administration,dietary)
COMP:N-N(of) (administration,__NODE__)
APPOS (__NODE__,dosage)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,1)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
COMP:N-N(of) (period,administration)
MOD_ATT:N-ADJ (administration,dietary)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (__NODE__,dosage)
COMP:N-N(of) (dosage,00.2percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,expression)
MOD_ATT:N-N (expression,week)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD:ADV-N (after,week)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 54

                                                                                        +-----------------------COMP:N-N(of)-----------------------+                                           +----------------------COMP:N-N(of)---------------------+                                                             
                                                                                        +-----------COMP:N-N(of)-----------+-------------COMP:N-N(of)-------------+                            |                         +---------COMP:N-N(of)--------+-------COMP:N-N(of)-------+                                  
      +-COMP:N-N(from)-+--------APPOS-------+              +--------COMP:N-N(of)--------+                       +-----------COMP:N-N(of)-----------+              |                +-------------COMP:N-N(of)------------+          +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+------COMP:N-N(after)------+      
      |          +MOD_A+        +MOD_ATT:N-A+-COMP:N-N(of)-+-COMP:N-N(with)-+      +MOD_+              +MOD_ATT:+COMP:N-N(o+           +MOD_ATT:N-A+-COMP:N-N(of)-+-COMP:N-N(with)-+COMP:N-N(of+                +MOD_ATT:+          |        +MOD_ATT:N+           |       +MOD_AT+      +MOD:+      +MOD_ATT:+      
      |          |     |        |           |              |                |      |    |              |        |          |           |           |              |                |           |                |        |          |        |         |           |       |      |      |    |      |        |      
 In liver from male __SP__ , dietary administration of __NODE__ ( with a dosage of 1 percent and a treatment period of 1 week ) and dietary administration of __NODE__ ( with a dosage of 00.2percent and a treatment period of 1 week ) decrease expression of __SP__ __NODE__ mRNA 1 week after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
APPOS (__SP__,administration)
MOD_ATT:N-ADJ (administration,dietary)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (__NODE__,dosage)
COMP:N-N(of) (__NODE__,percent)
MOD_ATT:N-ADJ (percent,1)
COMP:N-N(of) (percent,week)
COMP:N-N(of) (percent,administration)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
COMP:N-N(of) (period,administration)
COMP:N-N(of) (week,__NODE__)
MOD_ATT:N-ADJ (administration,dietary)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (__NODE__,dosage)
COMP:N-N(of) (dosage,00.2percent)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (00.2percent,expression)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,expression)
MOD_ATT:N-N (expression,week)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD:ADV-N (after,week)
MOD_ATT:N-N (treatment,initial)

Analyse 55

                                                                                        +-----------------------COMP:N-N(of)-----------------------+                                                                                                                                                                 
      +------------COMP:N-N(from)-----------+                               +------------COMP:N-N(of)-----------+                                  |                                                                                                                                                                 
      |          +--------MOD_ATT:N-N-------+                               |           +-----------COMP:N-N(of)-----------+-------------COMP:N-N(of)-------------+                                                      +---------COMP:N-N(of)--------+-------COMP:N-N(of)-------+                                  
      |          |     +----MOD_ATT:N-ADJ---+-------------APPOS-------------+COMP:N-N(of+                       +-----------COMP:N-N(of)-----------+              |                +-------------COMP:N-N(of)------------+          +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+------COMP:N-N(after)------+      
      |          |     |        +MOD_ATT:N-A+-COMP:N-N(of)-+                |      +MOD_+              +MOD_ATT:+COMP:N-N(o+           +MOD_ATT:N-A+-COMP:N-N(of)-+------APPOS-----+COMP:N-N(of+                +MOD_ATT:+          |        +MOD_ATT:N+           |       +MOD_AT+      +MOD:+      +MOD_ATT:+      
      |          |     |        |           |              |                |      |    |              |        |          |           |           |              |                |           |                |        |          |        |         |           |       |      |      |    |      |        |      
 In liver from male __SP__ , dietary administration of __NODE__ ( with a dosage of 1 percent and a treatment period of 1 week ) and dietary administration of __NODE__ ( with a dosage of 00.2percent and a treatment period of 1 week ) decrease expression of __SP__ __NODE__ mRNA 1 week after initial treatment .
COMP:N-N(from) (liver,administration)
MOD_ATT:N-N (administration,male)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-ADJ (administration,dietary)
COMP:N-N(of) (administration,__NODE__)
APPOS (administration,dosage)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,1)
COMP:N-N(of) (percent,week)
COMP:N-N(of) (percent,administration)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
COMP:N-N(of) (period,administration)
COMP:N-N(of) (week,__NODE__)
MOD_ATT:N-ADJ (administration,dietary)
COMP:N-N(of) (administration,__NODE__)
APPOS (__NODE__,dosage)
COMP:N-N(of) (dosage,00.2percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,expression)
MOD_ATT:N-N (expression,week)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD:ADV-N (after,week)
MOD_ATT:N-N (treatment,initial)

Analyse 56

                                                                                                                                                                                               +----------------------COMP:N-N(of)---------------------+                                                             
                                                                            +------------COMP:N-N(of)-----------+                                                 +---------------------COMP:N-N(of)---------------------+---------COMP:N-N(of)--------+-------COMP:N-N(of)-------+                                  
      +-COMP:N-N(from)-+--------APPOS-------+---------COMP:N-N(with)--------+COMP:N-N(of+-----------COMP:N-N(of)-----------+-------------COMP:N-N(of)-------------+--------COMP:N-N(of)--------+                         |          +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+------COMP:N-N(after)------+      
      |          +MOD_A+        +MOD_ATT:N-A+-COMP:N-N(of)-+                |      +MOD_+              +MOD_ATT:+COMP:N-N(o+           +MOD_ATT:N-A+-COMP:N-N(of)-+-COMP:N-N(with)-+           |                +MOD_ATT:+          |        +MOD_ATT:N+           |       +MOD_AT+      +MOD:+      +MOD_ATT:+      
      |          |     |        |           |              |                |      |    |              |        |          |           |           |              |                |           |                |        |          |        |         |           |       |      |      |    |      |        |      
 In liver from male __SP__ , dietary administration of __NODE__ ( with a dosage of 1 percent and a treatment period of 1 week ) and dietary administration of __NODE__ ( with a dosage of 00.2percent and a treatment period of 1 week ) decrease expression of __SP__ __NODE__ mRNA 1 week after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
APPOS (__SP__,administration)
MOD_ATT:N-ADJ (administration,dietary)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (administration,dosage)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,1)
COMP:N-N(of) (percent,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
COMP:N-N(of) (week,__NODE__)
MOD_ATT:N-ADJ (administration,dietary)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (__NODE__,dosage)
COMP:N-N(of) (__NODE__,00.2percent)
COMP:N-N(of) (__NODE__,period)
COMP:N-N(of) (00.2percent,expression)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,expression)
MOD_ATT:N-N (expression,week)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD:ADV-N (after,week)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 57

                                                                                        +-----------------------COMP:N-N(of)-----------------------+                                           +----------------------COMP:N-N(of)---------------------+                                                             
                                                                                        +-----------COMP:N-N(of)-----------+                       |                                           |                         +---------COMP:N-N(of)--------+-------COMP:N-N(of)-------+                                  
      +-COMP:N-N(from)-+--------APPOS-------+              +--------COMP:N-N(of)--------+                       +-----------COMP:N-N(of)-----------+---------COMP:N-N(with)--------+-------------COMP:N-N(of)------------+          +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+------COMP:N-N(after)------+      
      |          +MOD_A+        +MOD_ATT:N-A+-COMP:N-N(of)-+-COMP:N-N(with)-+      +MOD_+              +MOD_ATT:+COMP:N-N(o+           +MOD_ATT:N-A+-COMP:N-N(of)-+                +COMP:N-N(of+                +MOD_ATT:+          |        +MOD_ATT:N+           |       +MOD_AT+      +MOD:+      +MOD_ATT:+      
      |          |     |        |           |              |                |      |    |              |        |          |           |           |              |                |           |                |        |          |        |         |           |       |      |      |    |      |        |      
 In liver from male __SP__ , dietary administration of __NODE__ ( with a dosage of 1 percent and a treatment period of 1 week ) and dietary administration of __NODE__ ( with a dosage of 00.2percent and a treatment period of 1 week ) decrease expression of __SP__ __NODE__ mRNA 1 week after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
APPOS (__SP__,administration)
MOD_ATT:N-ADJ (administration,dietary)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (__NODE__,dosage)
COMP:N-N(of) (__NODE__,percent)
MOD_ATT:N-ADJ (percent,1)
COMP:N-N(of) (percent,week)
COMP:N-N(of) (percent,administration)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
COMP:N-N(of) (period,administration)
MOD_ATT:N-ADJ (administration,dietary)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (administration,dosage)
COMP:N-N(of) (dosage,00.2percent)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (00.2percent,expression)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,expression)
MOD_ATT:N-N (expression,week)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD:ADV-N (after,week)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 58

                                                                                        +-----------------------COMP:N-N(of)-----------------------+                                                                                                                                                                 
      +----------------APPOS----------------+                                           +-----------COMP:N-N(of)-----------+                       +----------------------------COMP:N-N(with)---------------------------+---------COMP:N-N(of)--------+-------COMP:N-N(of)-------+                                  
      +-COMP:N-N(from)-+                    |                               +COMP:N-N(of+                       +-----------COMP:N-N(of)-----------+---------COMP:N-N(with)--------+                                     |          +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+------COMP:N-N(after)------+      
      |          +MOD_A+        +MOD_ATT:N-A+-COMP:N-N(of)-+-COMP:N-N(with)-+      +MOD_+              +MOD_ATT:+COMP:N-N(o+           +MOD_ATT:N-A+-COMP:N-N(of)-+                +COMP:N-N(of+                +MOD_ATT:+          |        +MOD_ATT:N+           |       +MOD_AT+      +MOD:+      +MOD_ATT:+      
      |          |     |        |           |              |                |      |    |              |        |          |           |           |              |                |           |                |        |          |        |         |           |       |      |      |    |      |        |      
 In liver from male __SP__ , dietary administration of __NODE__ ( with a dosage of 1 percent and a treatment period of 1 week ) and dietary administration of __NODE__ ( with a dosage of 00.2percent and a treatment period of 1 week ) decrease expression of __SP__ __NODE__ mRNA 1 week after initial treatment .
COMP:N-N(from) (liver,__SP__)
APPOS (liver,administration)
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (administration,dietary)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (__NODE__,dosage)
COMP:N-N(of) (dosage,percent)
MOD_ATT:N-ADJ (percent,1)
COMP:N-N(of) (percent,week)
COMP:N-N(of) (percent,administration)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
COMP:N-N(of) (period,administration)
MOD_ATT:N-ADJ (administration,dietary)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (administration,dosage)
COMP:N-N(with) (administration,period)
COMP:N-N(of) (dosage,00.2percent)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,expression)
MOD_ATT:N-N (expression,week)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD:ADV-N (after,week)
MOD_ATT:N-N (treatment,initial)

Analyse 59

      +------------COMP:N-N(from)-----------+                                                                              +---------------------COMP:N-N(with)--------------------+           +----------------------COMP:N-N(of)---------------------+                                                             
      |          +-------MOD_ATT:N-ADJ------+                               +------------COMP:N-N(of)-----------+          +-------------COMP:N-N(of)-------------+                |           |                         +---------COMP:N-N(of)--------+-------COMP:N-N(of)-------+                                  
      |          |     +----MOD_ATT:N-ADJ---+                               +COMP:N-N(of+-----------COMP:N-N(of)-----------+                       +---------COMP:N-N(with)--------+           |                         |          +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+------COMP:N-N(after)------+      
      |          |     |        +MOD_ATT:N-A+-COMP:N-N(of)-+-COMP:N-N(with)-+      +MOD_+              +MOD_ATT:+COMP:N-N(o+           +MOD_ATT:N-A+-COMP:N-N(of)-+                +COMP:N-N(of+                +MOD_ATT:+          |        +MOD_ATT:N+           |       +MOD_AT+      +MOD:+      +MOD_ATT:+      
      |          |     |        |           |              |                |      |    |              |        |          |           |           |              |                |           |                |        |          |        |         |           |       |      |      |    |      |        |      
 In liver from male __SP__ , dietary administration of __NODE__ ( with a dosage of 1 percent and a treatment period of 1 week ) and dietary administration of __NODE__ ( with a dosage of 00.2percent and a treatment period of 1 week ) decrease expression of __SP__ __NODE__ mRNA 1 week after initial treatment .
COMP:N-N(from) (liver,administration)
MOD_ATT:N-ADJ (administration,male)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-ADJ (administration,dietary)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (__NODE__,dosage)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,1)
COMP:N-N(of) (percent,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
COMP:N-N(of) (week,__NODE__)
COMP:N-N(with) (week,dosage)
MOD_ATT:N-ADJ (administration,dietary)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (administration,dosage)
COMP:N-N(of) (dosage,00.2percent)
COMP:N-N(of) (00.2percent,expression)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,expression)
MOD_ATT:N-N (expression,week)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD:ADV-N (after,week)
MOD_ATT:N-N (treatment,initial)

Analyse 60

                                                                                        +-----------------------COMP:N-N(of)-----------------------+                                                                                                                                                                 
                                                                                        +-----------COMP:N-N(of)-----------+                       |                                                                     +---------COMP:N-N(of)--------+-------COMP:N-N(of)-------+                                  
      +-COMP:N-N(from)-+--------APPOS-------+              +--------COMP:N-N(of)--------+                       +-----------COMP:N-N(of)-----------+                               +-------------COMP:N-N(of)------------+          +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+------COMP:N-N(after)------+      
      |          +MOD_A+        +MOD_ATT:N-A+-COMP:N-N(of)-+-COMP:N-N(with)-+      +MOD_+              +MOD_ATT:+COMP:N-N(o+           +MOD_ATT:N-A+-COMP:N-N(of)-+-COMP:N-N(with)-+COMP:N-N(of+                +MOD_ATT:+          |        +MOD_ATT:N+           |       +MOD_AT+      +MOD:+      +MOD_ATT:+      
      |          |     |        |           |              |                |      |    |              |        |          |           |           |              |                |           |                |        |          |        |         |           |       |      |      |    |      |        |      
 In liver from male __SP__ , dietary administration of __NODE__ ( with a dosage of 1 percent and a treatment period of 1 week ) and dietary administration of __NODE__ ( with a dosage of 00.2percent and a treatment period of 1 week ) decrease expression of __SP__ __NODE__ mRNA 1 week after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
APPOS (__SP__,administration)
MOD_ATT:N-ADJ (administration,dietary)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (__NODE__,dosage)
COMP:N-N(of) (__NODE__,percent)
MOD_ATT:N-ADJ (percent,1)
COMP:N-N(of) (percent,week)
COMP:N-N(of) (percent,administration)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
COMP:N-N(of) (period,administration)
MOD_ATT:N-ADJ (administration,dietary)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (__NODE__,dosage)
COMP:N-N(of) (dosage,00.2percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,expression)
MOD_ATT:N-N (expression,week)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD:ADV-N (after,week)
MOD_ATT:N-N (treatment,initial)

Analyse 61

      +------------COMP:N-N(from)-----------+                                                                                                                                                  +----------------------COMP:N-N(of)---------------------+                                                             
      |          +--------MOD_ATT:N-N-------+                               +------------COMP:N-N(of)-----------+                                                                              |                         +---------COMP:N-N(of)--------+-------COMP:N-N(of)-------+                                  
      |          |     +----MOD_ATT:N-ADJ---+                               +COMP:N-N(of+                       +-----------COMP:N-N(of)-----------+-------------APPOS-------------+-------------COMP:N-N(of)------------+          +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+------COMP:N-N(after)------+      
      |          |     |        +MOD_ATT:N-A+-COMP:N-N(of)-+------APPOS-----+      +MOD_+              +MOD_ATT:+COMP:N-N(o+           +MOD_ATT:N-A+-COMP:N-N(of)-+                +COMP:N-N(of+                +MOD_ATT:+          |        +MOD_ATT:N+           |       +MOD_AT+      +MOD:+      +MOD_ATT:+      
      |          |     |        |           |              |                |      |    |              |        |          |           |           |              |                |           |                |        |          |        |         |           |       |      |      |    |      |        |      
 In liver from male __SP__ , dietary administration of __NODE__ ( with a dosage of 1 percent and a treatment period of 1 week ) and dietary administration of __NODE__ ( with a dosage of 00.2percent and a treatment period of 1 week ) decrease expression of __SP__ __NODE__ mRNA 1 week after initial treatment .
COMP:N-N(from) (liver,administration)
MOD_ATT:N-N (administration,male)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-ADJ (administration,dietary)
COMP:N-N(of) (administration,__NODE__)
APPOS (__NODE__,dosage)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,1)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
COMP:N-N(of) (period,administration)
MOD_ATT:N-ADJ (administration,dietary)
COMP:N-N(of) (administration,__NODE__)
APPOS (administration,dosage)
COMP:N-N(of) (dosage,00.2percent)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (00.2percent,expression)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,expression)
MOD_ATT:N-N (expression,week)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD:ADV-N (after,week)
MOD_ATT:N-N (treatment,initial)

Analyse 62

                                                                                        +-----------------------COMP:N-N(of)-----------------------+                                                                                                                                                                 
                                                                            +------------COMP:N-N(of)-----------+                                  |                                           +----------------------COMP:N-N(of)---------------------+                                                             
                                                                            |           +-----------COMP:N-N(of)-----------+-------------COMP:N-N(of)-------------+                            |                         +---------COMP:N-N(of)--------+-------COMP:N-N(of)-------+                                  
      +-COMP:N-N(from)-+--------APPOS-------+                               +COMP:N-N(of+                       +-----------COMP:N-N(of)-----------+              |                +-------------COMP:N-N(of)------------+          +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+------COMP:N-N(after)------+      
      |          +MOD_A+        +MOD_ATT:N-A+-COMP:N-N(of)-+------APPOS-----+      +MOD_+              +MOD_ATT:+COMP:N-N(o+           +MOD_ATT:N-A+-COMP:N-N(of)-+------APPOS-----+COMP:N-N(of+                +MOD_ATT:+          |        +MOD_ATT:N+           |       +MOD_AT+      +MOD:+      +MOD_ATT:+      
      |          |     |        |           |              |                |      |    |              |        |          |           |           |              |                |           |                |        |          |        |         |           |       |      |      |    |      |        |      
 In liver from male __SP__ , dietary administration of __NODE__ ( with a dosage of 1 percent and a treatment period of 1 week ) and dietary administration of __NODE__ ( with a dosage of 00.2percent and a treatment period of 1 week ) decrease expression of __SP__ __NODE__ mRNA 1 week after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
APPOS (__SP__,administration)
MOD_ATT:N-ADJ (administration,dietary)
COMP:N-N(of) (administration,__NODE__)
APPOS (__NODE__,dosage)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,1)
COMP:N-N(of) (percent,week)
COMP:N-N(of) (percent,administration)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
COMP:N-N(of) (period,administration)
COMP:N-N(of) (week,__NODE__)
MOD_ATT:N-ADJ (administration,dietary)
COMP:N-N(of) (administration,__NODE__)
APPOS (__NODE__,dosage)
COMP:N-N(of) (dosage,00.2percent)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (00.2percent,expression)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,expression)
MOD_ATT:N-N (expression,week)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD:ADV-N (after,week)
MOD_ATT:N-N (treatment,initial)

Analyse 63

      +------------COMP:N-N(from)-----------+                                                                                                                                                  +----------------------COMP:N-N(of)---------------------+                                                             
      |          +--------MOD_ATT:N-N-------+                               +------------COMP:N-N(of)-----------+                                                                              |                         +---------COMP:N-N(of)--------+-------COMP:N-N(of)-------+                                  
      |          |     +----MOD_ATT:N-ADJ---+-------------APPOS-------------+COMP:N-N(of+-----------COMP:N-N(of)-----------+-------------COMP:N-N(of)-------------+                +-------------COMP:N-N(of)------------+          +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+------COMP:N-N(after)------+      
      |          |     |        +MOD_ATT:N-A+-COMP:N-N(of)-+                |      +MOD_+              +MOD_ATT:+COMP:N-N(o+           +MOD_ATT:N-A+-COMP:N-N(of)-+-COMP:N-N(with)-+COMP:N-N(of+                +MOD_ATT:+          |        +MOD_ATT:N+           |       +MOD_AT+      +MOD:+      +MOD_ATT:+      
      |          |     |        |           |              |                |      |    |              |        |          |           |           |              |                |           |                |        |          |        |         |           |       |      |      |    |      |        |      
 In liver from male __SP__ , dietary administration of __NODE__ ( with a dosage of 1 percent and a treatment period of 1 week ) and dietary administration of __NODE__ ( with a dosage of 00.2percent and a treatment period of 1 week ) decrease expression of __SP__ __NODE__ mRNA 1 week after initial treatment .
COMP:N-N(from) (liver,administration)
MOD_ATT:N-N (administration,male)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-ADJ (administration,dietary)
COMP:N-N(of) (administration,__NODE__)
APPOS (administration,dosage)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,1)
COMP:N-N(of) (percent,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
COMP:N-N(of) (week,__NODE__)
MOD_ATT:N-ADJ (administration,dietary)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (__NODE__,dosage)
COMP:N-N(of) (dosage,00.2percent)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (00.2percent,expression)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,expression)
MOD_ATT:N-N (expression,week)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD:ADV-N (after,week)
MOD_ATT:N-N (treatment,initial)

Analyse 64

                                                                                        +-----------------------COMP:N-N(of)-----------------------+                                                                                                                                                                 
                                                                            +------------COMP:N-N(of)-----------+                                  |                                                                                                                                                                 
                                                                            |           +-----------COMP:N-N(of)-----------+                       |                                                                     +---------COMP:N-N(of)--------+-------COMP:N-N(of)-------+                                  
      +-COMP:N-N(from)-+--------APPOS-------+                               +COMP:N-N(of+                       +-----------COMP:N-N(of)-----------+                               +-------------COMP:N-N(of)------------+          +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+------COMP:N-N(after)------+      
      |          +MOD_A+        +MOD_ATT:N-A+-COMP:N-N(of)-+------APPOS-----+      +MOD_+              +MOD_ATT:+COMP:N-N(o+           +MOD_ATT:N-A+-COMP:N-N(of)-+------APPOS-----+COMP:N-N(of+                +MOD_ATT:+          |        +MOD_ATT:N+           |       +MOD_AT+      +MOD:+      +MOD_ATT:+      
      |          |     |        |           |              |                |      |    |              |        |          |           |           |              |                |           |                |        |          |        |         |           |       |      |      |    |      |        |      
 In liver from male __SP__ , dietary administration of __NODE__ ( with a dosage of 1 percent and a treatment period of 1 week ) and dietary administration of __NODE__ ( with a dosage of 00.2percent and a treatment period of 1 week ) decrease expression of __SP__ __NODE__ mRNA 1 week after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
APPOS (__SP__,administration)
MOD_ATT:N-ADJ (administration,dietary)
COMP:N-N(of) (administration,__NODE__)
APPOS (__NODE__,dosage)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,1)
COMP:N-N(of) (percent,week)
COMP:N-N(of) (percent,administration)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
COMP:N-N(of) (period,administration)
MOD_ATT:N-ADJ (administration,dietary)
COMP:N-N(of) (administration,__NODE__)
APPOS (__NODE__,dosage)
COMP:N-N(of) (dosage,00.2percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,expression)
MOD_ATT:N-N (expression,week)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD:ADV-N (after,week)
MOD_ATT:N-N (treatment,initial)

Analyse 65

                                                                                                                                                                                               +----------------------COMP:N-N(of)---------------------+                                                             
                                                                            +------------COMP:N-N(of)-----------+                                                                              |                         +---------COMP:N-N(of)--------+-------COMP:N-N(of)-------+                                  
      +-COMP:N-N(from)-+--------APPOS-------+-------------APPOS-------------+COMP:N-N(of+                       +-----------COMP:N-N(of)-----------+                               +-------------COMP:N-N(of)------------+          +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+------COMP:N-N(after)------+      
      |          +MOD_A+        +MOD_ATT:N-A+-COMP:N-N(of)-+                |      +MOD_+              +MOD_ATT:+COMP:N-N(o+           +MOD_ATT:N-A+-COMP:N-N(of)-+------APPOS-----+COMP:N-N(of+                +MOD_ATT:+          |        +MOD_ATT:N+           |       +MOD_AT+      +MOD:+      +MOD_ATT:+      
      |          |     |        |           |              |                |      |    |              |        |          |           |           |              |                |           |                |        |          |        |         |           |       |      |      |    |      |        |      
 In liver from male __SP__ , dietary administration of __NODE__ ( with a dosage of 1 percent and a treatment period of 1 week ) and dietary administration of __NODE__ ( with a dosage of 00.2percent and a treatment period of 1 week ) decrease expression of __SP__ __NODE__ mRNA 1 week after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
APPOS (__SP__,administration)
MOD_ATT:N-ADJ (administration,dietary)
COMP:N-N(of) (administration,__NODE__)
APPOS (administration,dosage)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,1)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
COMP:N-N(of) (period,administration)
MOD_ATT:N-ADJ (administration,dietary)
COMP:N-N(of) (administration,__NODE__)
APPOS (__NODE__,dosage)
COMP:N-N(of) (dosage,00.2percent)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (00.2percent,expression)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,expression)
MOD_ATT:N-N (expression,week)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD:ADV-N (after,week)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 66

                                                                                                                                                                                               +----------------------COMP:N-N(of)---------------------+                                                             
      +----------------APPOS----------------+                               +------------COMP:N-N(of)-----------+                                                                              |                         +---------COMP:N-N(of)--------+-------COMP:N-N(of)-------+                                  
      +-COMP:N-N(from)-+                    |                               +COMP:N-N(of+                       +-----------COMP:N-N(of)-----------+                               +-------------COMP:N-N(of)------------+          +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+------COMP:N-N(after)------+      
      |          +MOD_A+        +MOD_ATT:N-A+-COMP:N-N(of)-+------APPOS-----+      +MOD_+              +MOD_ATT:+COMP:N-N(o+           +MOD_ATT:N-A+-COMP:N-N(of)-+------APPOS-----+COMP:N-N(of+                +MOD_ATT:+          |        +MOD_ATT:N+           |       +MOD_AT+      +MOD:+      +MOD_ATT:+      
      |          |     |        |           |              |                |      |    |              |        |          |           |           |              |                |           |                |        |          |        |         |           |       |      |      |    |      |        |      
 In liver from male __SP__ , dietary administration of __NODE__ ( with a dosage of 1 percent and a treatment period of 1 week ) and dietary administration of __NODE__ ( with a dosage of 00.2percent and a treatment period of 1 week ) decrease expression of __SP__ __NODE__ mRNA 1 week after initial treatment .
COMP:N-N(from) (liver,__SP__)
APPOS (liver,administration)
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (administration,dietary)
COMP:N-N(of) (administration,__NODE__)
APPOS (__NODE__,dosage)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,1)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
COMP:N-N(of) (period,administration)
MOD_ATT:N-ADJ (administration,dietary)
COMP:N-N(of) (administration,__NODE__)
APPOS (__NODE__,dosage)
COMP:N-N(of) (dosage,00.2percent)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (00.2percent,expression)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,expression)
MOD_ATT:N-N (expression,week)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD:ADV-N (after,week)
MOD_ATT:N-N (treatment,initial)

Analyse 67

      +----------------APPOS----------------+                               +------------COMP:N-N(of)-----------+                                                                                                        +---------COMP:N-N(of)--------+-------COMP:N-N(of)-------+                                  
      +-COMP:N-N(from)-+                    +-------------APPOS-------------+COMP:N-N(of+                       +-----------COMP:N-N(of)-----------+-------------APPOS-------------+-------------COMP:N-N(of)------------+          +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+------COMP:N-N(after)------+      
      |          +MOD_A+        +MOD_ATT:N-A+-COMP:N-N(of)-+                |      +MOD_+              +MOD_ATT:+COMP:N-N(o+           +MOD_ATT:N-A+-COMP:N-N(of)-+                +COMP:N-N(of+                +MOD_ATT:+          |        +MOD_ATT:N+           |       +MOD_AT+      +MOD:+      +MOD_ATT:+      
      |          |     |        |           |              |                |      |    |              |        |          |           |           |              |                |           |                |        |          |        |         |           |       |      |      |    |      |        |      
 In liver from male __SP__ , dietary administration of __NODE__ ( with a dosage of 1 percent and a treatment period of 1 week ) and dietary administration of __NODE__ ( with a dosage of 00.2percent and a treatment period of 1 week ) decrease expression of __SP__ __NODE__ mRNA 1 week after initial treatment .
COMP:N-N(from) (liver,__SP__)
APPOS (liver,administration)
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (administration,dietary)
COMP:N-N(of) (administration,__NODE__)
APPOS (administration,dosage)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,1)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
COMP:N-N(of) (period,administration)
MOD_ATT:N-ADJ (administration,dietary)
COMP:N-N(of) (administration,__NODE__)
APPOS (administration,dosage)
COMP:N-N(of) (dosage,00.2percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,expression)
MOD_ATT:N-N (expression,week)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD:ADV-N (after,week)
MOD_ATT:N-N (treatment,initial)

Analyse 68

                                                                                                                                                                                               +----------------------COMP:N-N(of)---------------------+                                                             
      +----------------APPOS----------------+                               +------------COMP:N-N(of)-----------+                                                 +---------------------COMP:N-N(of)---------------------+---------COMP:N-N(of)--------+-------COMP:N-N(of)-------+                                  
      +-COMP:N-N(from)-+                    |                               +COMP:N-N(of+-----------COMP:N-N(of)-----------+-------------COMP:N-N(of)-------------+--------COMP:N-N(of)--------+                         |          +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+------COMP:N-N(after)------+      
      |          +MOD_A+        +MOD_ATT:N-A+-COMP:N-N(of)-+------APPOS-----+      +MOD_+              +MOD_ATT:+COMP:N-N(o+           +MOD_ATT:N-A+-COMP:N-N(of)-+-COMP:N-N(with)-+           |                +MOD_ATT:+          |        +MOD_ATT:N+           |       +MOD_AT+      +MOD:+      +MOD_ATT:+      
      |          |     |        |           |              |                |      |    |              |        |          |           |           |              |                |           |                |        |          |        |         |           |       |      |      |    |      |        |      
 In liver from male __SP__ , dietary administration of __NODE__ ( with a dosage of 1 percent and a treatment period of 1 week ) and dietary administration of __NODE__ ( with a dosage of 00.2percent and a treatment period of 1 week ) decrease expression of __SP__ __NODE__ mRNA 1 week after initial treatment .
COMP:N-N(from) (liver,__SP__)
APPOS (liver,administration)
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (administration,dietary)
COMP:N-N(of) (administration,__NODE__)
APPOS (__NODE__,dosage)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,1)
COMP:N-N(of) (percent,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
COMP:N-N(of) (week,__NODE__)
MOD_ATT:N-ADJ (administration,dietary)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (__NODE__,dosage)
COMP:N-N(of) (__NODE__,00.2percent)
COMP:N-N(of) (__NODE__,period)
COMP:N-N(of) (00.2percent,expression)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,expression)
MOD_ATT:N-N (expression,week)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD:ADV-N (after,week)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 69

                                                                                        +-----------------------COMP:N-N(of)-----------------------+                                                                                                                                                                 
                                                                                        +-----------COMP:N-N(of)-----------+-------------COMP:N-N(of)-------------+                                                      +---------COMP:N-N(of)--------+-------COMP:N-N(of)-------+                                  
      +-COMP:N-N(from)-+--------APPOS-------+                               +COMP:N-N(of+                       +-----------COMP:N-N(of)-----------+              |                +-------------COMP:N-N(of)------------+          +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+------COMP:N-N(after)------+      
      |          +MOD_A+        +MOD_ATT:N-A+-COMP:N-N(of)-+-COMP:N-N(with)-+      +MOD_+              +MOD_ATT:+COMP:N-N(o+           +MOD_ATT:N-A+-COMP:N-N(of)-+------APPOS-----+COMP:N-N(of+                +MOD_ATT:+          |        +MOD_ATT:N+           |       +MOD_AT+      +MOD:+      +MOD_ATT:+      
      |          |     |        |           |              |                |      |    |              |        |          |           |           |              |                |           |                |        |          |        |         |           |       |      |      |    |      |        |      
 In liver from male __SP__ , dietary administration of __NODE__ ( with a dosage of 1 percent and a treatment period of 1 week ) and dietary administration of __NODE__ ( with a dosage of 00.2percent and a treatment period of 1 week ) decrease expression of __SP__ __NODE__ mRNA 1 week after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
APPOS (__SP__,administration)
MOD_ATT:N-ADJ (administration,dietary)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (__NODE__,dosage)
COMP:N-N(of) (dosage,percent)
MOD_ATT:N-ADJ (percent,1)
COMP:N-N(of) (percent,week)
COMP:N-N(of) (percent,administration)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
COMP:N-N(of) (period,administration)
COMP:N-N(of) (week,__NODE__)
MOD_ATT:N-ADJ (administration,dietary)
COMP:N-N(of) (administration,__NODE__)
APPOS (__NODE__,dosage)
COMP:N-N(of) (dosage,00.2percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,expression)
MOD_ATT:N-N (expression,week)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD:ADV-N (after,week)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 70

      +------------COMP:N-N(from)-----------+                                                                              +----------------------------------------COMP:N-N(with)---------------------------------------+                                                                                           
      |          +--------MOD_ATT:N-N-------+                                                                              +---------------------COMP:N-N(with)--------------------+                                     +---------COMP:N-N(of)--------+-------COMP:N-N(of)-------+                                  
      |          |     +----MOD_ATT:N-ADJ---+---------COMP:N-N(with)--------+COMP:N-N(of+-----------COMP:N-N(of)-----------+                                      +--------------------COMP:N-N(with)--------------------+          +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+------COMP:N-N(after)------+      
      |          |     |        +MOD_ATT:N-A+-COMP:N-N(of)-+                |      +MOD_+              +MOD_ATT:+COMP:N-N(o+           +MOD_ATT:N-A+-COMP:N-N(of)-+-COMP:N-N(with)-+COMP:N-N(of+                +MOD_ATT:+          |        +MOD_ATT:N+           |       +MOD_AT+      +MOD:+      +MOD_ATT:+      
      |          |     |        |           |              |                |      |    |              |        |          |           |           |              |                |           |                |        |          |        |         |           |       |      |      |    |      |        |      
 In liver from male __SP__ , dietary administration of __NODE__ ( with a dosage of 1 percent and a treatment period of 1 week ) and dietary administration of __NODE__ ( with a dosage of 00.2percent and a treatment period of 1 week ) decrease expression of __SP__ __NODE__ mRNA 1 week after initial treatment .
COMP:N-N(from) (liver,administration)
MOD_ATT:N-N (administration,male)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-ADJ (administration,dietary)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (administration,dosage)
COMP:N-N(of) (dosage,percent)
MOD_ATT:N-ADJ (percent,1)
COMP:N-N(of) (percent,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
COMP:N-N(with) (week,dosage)
COMP:N-N(with) (week,period)
MOD_ATT:N-ADJ (administration,dietary)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (__NODE__,dosage)
COMP:N-N(with) (__NODE__,period)
COMP:N-N(of) (dosage,00.2percent)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,expression)
MOD_ATT:N-N (expression,week)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD:ADV-N (after,week)
MOD_ATT:N-N (treatment,initial)

Analyse 71

      +------------COMP:N-N(from)-----------+                                                                                                                                                                                                                                                                        
      |          +--------MOD_ATT:N-N-------+                                                                                                                                                                            +---------COMP:N-N(of)--------+-------COMP:N-N(of)-------+                                  
      |          |     +----MOD_ATT:N-ADJ---+              +--------COMP:N-N(of)--------+-----------COMP:N-N(of)-----------+-------------COMP:N-N(of)-------------+                +-------------COMP:N-N(of)------------+          +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+------COMP:N-N(after)------+      
      |          |     |        +MOD_ATT:N-A+-COMP:N-N(of)-+-COMP:N-N(with)-+      +MOD_+              +MOD_ATT:+COMP:N-N(o+           +MOD_ATT:N-A+-COMP:N-N(of)-+-COMP:N-N(with)-+COMP:N-N(of+                +MOD_ATT:+          |        +MOD_ATT:N+           |       +MOD_AT+      +MOD:+      +MOD_ATT:+      
      |          |     |        |           |              |                |      |    |              |        |          |           |           |              |                |           |                |        |          |        |         |           |       |      |      |    |      |        |      
 In liver from male __SP__ , dietary administration of __NODE__ ( with a dosage of 1 percent and a treatment period of 1 week ) and dietary administration of __NODE__ ( with a dosage of 00.2percent and a treatment period of 1 week ) decrease expression of __SP__ __NODE__ mRNA 1 week after initial treatment .
COMP:N-N(from) (liver,administration)
MOD_ATT:N-N (administration,male)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-ADJ (administration,dietary)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (__NODE__,dosage)
COMP:N-N(of) (__NODE__,percent)
MOD_ATT:N-ADJ (percent,1)
COMP:N-N(of) (percent,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
COMP:N-N(of) (week,__NODE__)
MOD_ATT:N-ADJ (administration,dietary)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (__NODE__,dosage)
COMP:N-N(of) (dosage,00.2percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,expression)
MOD_ATT:N-N (expression,week)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD:ADV-N (after,week)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 72

                                                                                        +-----------------------COMP:N-N(of)-----------------------+                                                                                                                                                                 
      +----------------APPOS----------------+                                           +-----------COMP:N-N(of)-----------+                       |              +---------------------COMP:N-N(of)---------------------+---------COMP:N-N(of)--------+-------COMP:N-N(of)-------+                                  
      +-COMP:N-N(from)-+                    |                               +COMP:N-N(of+                       +-----------COMP:N-N(of)-----------+              +--------COMP:N-N(of)--------+                         |          +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+------COMP:N-N(after)------+      
      |          +MOD_A+        +MOD_ATT:N-A+-COMP:N-N(of)-+------APPOS-----+      +MOD_+              +MOD_ATT:+COMP:N-N(o+           +MOD_ATT:N-A+-COMP:N-N(of)-+-COMP:N-N(with)-+           |                +MOD_ATT:+          |        +MOD_ATT:N+           |       +MOD_AT+      +MOD:+      +MOD_ATT:+      
      |          |     |        |           |              |                |      |    |              |        |          |           |           |              |                |           |                |        |          |        |         |           |       |      |      |    |      |        |      
 In liver from male __SP__ , dietary administration of __NODE__ ( with a dosage of 1 percent and a treatment period of 1 week ) and dietary administration of __NODE__ ( with a dosage of 00.2percent and a treatment period of 1 week ) decrease expression of __SP__ __NODE__ mRNA 1 week after initial treatment .
COMP:N-N(from) (liver,__SP__)
APPOS (liver,administration)
MOD_ATT:N-ADJ (__SP__,male)
MOD_ATT:N-ADJ (administration,dietary)
COMP:N-N(of) (administration,__NODE__)
APPOS (__NODE__,dosage)
COMP:N-N(of) (dosage,percent)
MOD_ATT:N-ADJ (percent,1)
COMP:N-N(of) (percent,week)
COMP:N-N(of) (percent,administration)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
COMP:N-N(of) (period,administration)
MOD_ATT:N-ADJ (administration,dietary)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (__NODE__,dosage)
COMP:N-N(of) (__NODE__,00.2percent)
COMP:N-N(of) (__NODE__,period)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,expression)
MOD_ATT:N-N (expression,week)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD:ADV-N (after,week)
MOD_ATT:N-N (treatment,initial)

Analyse 73

                                                                                        +-----------------------COMP:N-N(of)-----------------------+                                                                                                                                                                 
                                                                                        |                                  +---------------------COMP:N-N(with)--------------------+           +----------------------COMP:N-N(of)---------------------+                                                             
      +----------------APPOS----------------+                                           +-----------COMP:N-N(of)-----------+-------------COMP:N-N(of)-------------+                |           |                         +---------COMP:N-N(of)--------+-------COMP:N-N(of)-------+                                  
      +-COMP:N-N(from)-+                    |              +--------COMP:N-N(of)--------+                       +-----------COMP:N-N(of)-----------+---------COMP:N-N(with)--------+           |                         |          +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+------COMP:N-N(after)------+      
      |          +MOD_A+        +MOD_ATT:N-A+-COMP:N-N(of)-+-COMP:N-N(with)-+      +MOD_+              +MOD_ATT:+COMP:N-N(o+           +MOD_ATT:N-A+-COMP:N-N(of)-+                +COMP:N-N(of+                +MOD_ATT:+          |        +MOD_ATT:N+           |       +MOD_AT+      +MOD:+      +MOD_ATT:+      
      |          |     |        |           |              |                |      |    |              |        |          |           |           |              |                |           |                |        |          |        |         |           |       |      |      |    |      |        |      
 In liver from male __SP__ , dietary administration of __NODE__ ( with a dosage of 1 percent and a treatment period of 1 week ) and dietary administration of __NODE__ ( with a dosage of 00.2percent and a treatment period of 1 week ) decrease expression of __SP__ __NODE__ mRNA 1 week after initial treatment .
COMP:N-N(from) (liver,__SP__)
APPOS (liver,administration)
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (administration,dietary)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (__NODE__,dosage)
COMP:N-N(of) (__NODE__,percent)
MOD_ATT:N-ADJ (percent,1)
COMP:N-N(of) (percent,week)
COMP:N-N(of) (percent,administration)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
COMP:N-N(of) (period,administration)
COMP:N-N(of) (week,__NODE__)
COMP:N-N(with) (week,dosage)
MOD_ATT:N-ADJ (administration,dietary)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (administration,dosage)
COMP:N-N(of) (dosage,00.2percent)
COMP:N-N(of) (00.2percent,expression)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,expression)
MOD_ATT:N-N (expression,week)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD:ADV-N (after,week)
MOD_ATT:N-N (treatment,initial)

Analyse 74

                                                                                                                           +----------------------------------------COMP:N-N(with)---------------------------------------+                                                                                           
      +----------------APPOS----------------+                                                                              +---------------------COMP:N-N(with)--------------------+                                     +---------COMP:N-N(of)--------+-------COMP:N-N(of)-------+                                  
      +-COMP:N-N(from)-+                    |              +--------COMP:N-N(of)--------+-----------COMP:N-N(of)-----------+                                      +--------------------COMP:N-N(with)--------------------+          +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+------COMP:N-N(after)------+      
      |          +MOD_A+        +MOD_ATT:N-A+-COMP:N-N(of)-+-COMP:N-N(with)-+      +MOD_+              +MOD_ATT:+COMP:N-N(o+           +MOD_ATT:N-A+-COMP:N-N(of)-+-COMP:N-N(with)-+COMP:N-N(of+                +MOD_ATT:+          |        +MOD_ATT:N+           |       +MOD_AT+      +MOD:+      +MOD_ATT:+      
      |          |     |        |           |              |                |      |    |              |        |          |           |           |              |                |           |                |        |          |        |         |           |       |      |      |    |      |        |      
 In liver from male __SP__ , dietary administration of __NODE__ ( with a dosage of 1 percent and a treatment period of 1 week ) and dietary administration of __NODE__ ( with a dosage of 00.2percent and a treatment period of 1 week ) decrease expression of __SP__ __NODE__ mRNA 1 week after initial treatment .
COMP:N-N(from) (liver,__SP__)
APPOS (liver,administration)
MOD_ATT:N-N (__SP__,male)
MOD_ATT:N-ADJ (administration,dietary)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (__NODE__,dosage)
COMP:N-N(of) (__NODE__,percent)
MOD_ATT:N-ADJ (percent,1)
COMP:N-N(of) (percent,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
COMP:N-N(with) (week,dosage)
COMP:N-N(with) (week,period)
MOD_ATT:N-ADJ (administration,dietary)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (__NODE__,dosage)
COMP:N-N(with) (__NODE__,period)
COMP:N-N(of) (dosage,00.2percent)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,expression)
MOD_ATT:N-N (expression,week)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD:ADV-N (after,week)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 75

                                                                                                                                                                                               +----------------------COMP:N-N(of)---------------------+                                                             
                                                                            +------------COMP:N-N(of)-----------+                                                                              |                         +---------COMP:N-N(of)--------+-------COMP:N-N(of)-------+                                  
      +-COMP:N-N(from)-+--------APPOS-------+                               +COMP:N-N(of+-----------COMP:N-N(of)-----------+---------------------COMP:N-N(with)--------------------+           |                         |          +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+------COMP:N-N(after)------+      
      |          +MOD_A+        +MOD_ATT:N-A+-COMP:N-N(of)-+-COMP:N-N(with)-+      +MOD_+              +MOD_ATT:+COMP:N-N(o+           +MOD_ATT:N-A+-COMP:N-N(of)-+-COMP:N-N(with)-+COMP:N-N(of+                +MOD_ATT:+          |        +MOD_ATT:N+           |       +MOD_AT+      +MOD:+      +MOD_ATT:+      
      |          |     |        |           |              |                |      |    |              |        |          |           |           |              |                |           |                |        |          |        |         |           |       |      |      |    |      |        |      
 In liver from male __SP__ , dietary administration of __NODE__ ( with a dosage of 1 percent and a treatment period of 1 week ) and dietary administration of __NODE__ ( with a dosage of 00.2percent and a treatment period of 1 week ) decrease expression of __SP__ __NODE__ mRNA 1 week after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
APPOS (__SP__,administration)
MOD_ATT:N-ADJ (administration,dietary)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (__NODE__,dosage)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,1)
COMP:N-N(of) (percent,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
COMP:N-N(with) (week,dosage)
MOD_ATT:N-ADJ (administration,dietary)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (__NODE__,dosage)
COMP:N-N(of) (dosage,00.2percent)
COMP:N-N(of) (00.2percent,expression)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,expression)
MOD_ATT:N-N (expression,week)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD:ADV-N (after,week)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 76

                                                                                        +-----------------------COMP:N-N(of)-----------------------+                                                                                                                                                                 
                                                                                        +-----------COMP:N-N(of)-----------+-------------COMP:N-N(of)-------------+                                                      +---------COMP:N-N(of)--------+-------COMP:N-N(of)-------+                                  
      +-COMP:N-N(from)-+--------APPOS-------+-------------APPOS-------------+COMP:N-N(of+                       +-----------COMP:N-N(of)-----------+              |                +-------------COMP:N-N(of)------------+          +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+------COMP:N-N(after)------+      
      |          +MOD_A+        +MOD_ATT:N-A+-COMP:N-N(of)-+                |      +MOD_+              +MOD_ATT:+COMP:N-N(o+           +MOD_ATT:N-A+-COMP:N-N(of)-+------APPOS-----+COMP:N-N(of+                +MOD_ATT:+          |        +MOD_ATT:N+           |       +MOD_AT+      +MOD:+      +MOD_ATT:+      
      |          |     |        |           |              |                |      |    |              |        |          |           |           |              |                |           |                |        |          |        |         |           |       |      |      |    |      |        |      
 In liver from male __SP__ , dietary administration of __NODE__ ( with a dosage of 1 percent and a treatment period of 1 week ) and dietary administration of __NODE__ ( with a dosage of 00.2percent and a treatment period of 1 week ) decrease expression of __SP__ __NODE__ mRNA 1 week after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
APPOS (__SP__,administration)
MOD_ATT:N-ADJ (administration,dietary)
COMP:N-N(of) (administration,__NODE__)
APPOS (administration,dosage)
COMP:N-N(of) (dosage,percent)
MOD_ATT:N-ADJ (percent,1)
COMP:N-N(of) (percent,week)
COMP:N-N(of) (percent,administration)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
COMP:N-N(of) (period,administration)
COMP:N-N(of) (week,__NODE__)
MOD_ATT:N-ADJ (administration,dietary)
COMP:N-N(of) (administration,__NODE__)
APPOS (__NODE__,dosage)
COMP:N-N(of) (dosage,00.2percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,expression)
MOD_ATT:N-N (expression,week)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD:ADV-N (after,week)
MOD_ATT:N-N (treatment,initial)

Analyse 77

      +------------COMP:N-N(from)-----------+                                                                                                                                                  +----------------------COMP:N-N(of)---------------------+                                                             
      |          +--------MOD_ATT:N-N-------+                               +------------COMP:N-N(of)-----------+                                                                              |                         +---------COMP:N-N(of)--------+-------COMP:N-N(of)-------+                                  
      |          |     +----MOD_ATT:N-ADJ---+-------------APPOS-------------+COMP:N-N(of+-----------COMP:N-N(of)-----------+---------------------COMP:N-N(with)--------------------+           |                         |          +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+------COMP:N-N(after)------+      
      |          |     |        +MOD_ATT:N-A+-COMP:N-N(of)-+                |      +MOD_+              +MOD_ATT:+COMP:N-N(o+           +MOD_ATT:N-A+-COMP:N-N(of)-+-COMP:N-N(with)-+COMP:N-N(of+                +MOD_ATT:+          |        +MOD_ATT:N+           |       +MOD_AT+      +MOD:+      +MOD_ATT:+      
      |          |     |        |           |              |                |      |    |              |        |          |           |           |              |                |           |                |        |          |        |         |           |       |      |      |    |      |        |      
 In liver from male __SP__ , dietary administration of __NODE__ ( with a dosage of 1 percent and a treatment period of 1 week ) and dietary administration of __NODE__ ( with a dosage of 00.2percent and a treatment period of 1 week ) decrease expression of __SP__ __NODE__ mRNA 1 week after initial treatment .
COMP:N-N(from) (liver,administration)
MOD_ATT:N-N (administration,male)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-ADJ (administration,dietary)
COMP:N-N(of) (administration,__NODE__)
APPOS (administration,dosage)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,1)
COMP:N-N(of) (percent,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
COMP:N-N(with) (week,dosage)
MOD_ATT:N-ADJ (administration,dietary)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (__NODE__,dosage)
COMP:N-N(of) (dosage,00.2percent)
COMP:N-N(of) (00.2percent,expression)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,expression)
MOD_ATT:N-N (expression,week)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD:ADV-N (after,week)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 78

                                                                                        +-----------------------COMP:N-N(of)-----------------------+                                                                                                                                                                 
                                                                                        +-----------COMP:N-N(of)-----------+                       |                                                                     +---------COMP:N-N(of)--------+-------COMP:N-N(of)-------+                                  
      +-COMP:N-N(from)-+--------APPOS-------+-------------APPOS-------------+COMP:N-N(of+                       +-----------COMP:N-N(of)-----------+                               +-------------COMP:N-N(of)------------+          +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+------COMP:N-N(after)------+      
      |          +MOD_A+        +MOD_ATT:N-A+-COMP:N-N(of)-+                |      +MOD_+              +MOD_ATT:+COMP:N-N(o+           +MOD_ATT:N-A+-COMP:N-N(of)-+------APPOS-----+COMP:N-N(of+                +MOD_ATT:+          |        +MOD_ATT:N+           |       +MOD_AT+      +MOD:+      +MOD_ATT:+      
      |          |     |        |           |              |                |      |    |              |        |          |           |           |              |                |           |                |        |          |        |         |           |       |      |      |    |      |        |      
 In liver from male __SP__ , dietary administration of __NODE__ ( with a dosage of 1 percent and a treatment period of 1 week ) and dietary administration of __NODE__ ( with a dosage of 00.2percent and a treatment period of 1 week ) decrease expression of __SP__ __NODE__ mRNA 1 week after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
APPOS (__SP__,administration)
MOD_ATT:N-ADJ (administration,dietary)
COMP:N-N(of) (administration,__NODE__)
APPOS (administration,dosage)
COMP:N-N(of) (dosage,percent)
MOD_ATT:N-ADJ (percent,1)
COMP:N-N(of) (percent,week)
COMP:N-N(of) (percent,administration)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
COMP:N-N(of) (period,administration)
MOD_ATT:N-ADJ (administration,dietary)
COMP:N-N(of) (administration,__NODE__)
APPOS (__NODE__,dosage)
COMP:N-N(of) (dosage,00.2percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,expression)
MOD_ATT:N-N (expression,week)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD:ADV-N (after,week)
MOD_ATT:N-N (treatment,initial)

Analyse 79

                                                                                                                                                                                               +----------------------COMP:N-N(of)---------------------+                                                             
                                                                            +------------COMP:N-N(of)-----------+                                                                              |                         +---------COMP:N-N(of)--------+-------COMP:N-N(of)-------+                                  
      +-COMP:N-N(from)-+--------APPOS-------+                               +COMP:N-N(of+-----------COMP:N-N(of)-----------+---------------------COMP:N-N(with)--------------------+           |                         |          +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+------COMP:N-N(after)------+      
      |          +MOD_A+        +MOD_ATT:N-A+-COMP:N-N(of)-+------APPOS-----+      +MOD_+              +MOD_ATT:+COMP:N-N(o+           +MOD_ATT:N-A+-COMP:N-N(of)-+-COMP:N-N(with)-+COMP:N-N(of+                +MOD_ATT:+          |        +MOD_ATT:N+           |       +MOD_AT+      +MOD:+      +MOD_ATT:+      
      |          |     |        |           |              |                |      |    |              |        |          |           |           |              |                |           |                |        |          |        |         |           |       |      |      |    |      |        |      
 In liver from male __SP__ , dietary administration of __NODE__ ( with a dosage of 1 percent and a treatment period of 1 week ) and dietary administration of __NODE__ ( with a dosage of 00.2percent and a treatment period of 1 week ) decrease expression of __SP__ __NODE__ mRNA 1 week after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
APPOS (__SP__,administration)
MOD_ATT:N-ADJ (administration,dietary)
COMP:N-N(of) (administration,__NODE__)
APPOS (__NODE__,dosage)
COMP:N-N(of) (dosage,percent)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-ADJ (percent,1)
COMP:N-N(of) (percent,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
COMP:N-N(with) (week,dosage)
MOD_ATT:N-ADJ (administration,dietary)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (__NODE__,dosage)
COMP:N-N(of) (dosage,00.2percent)
COMP:N-N(of) (00.2percent,expression)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,expression)
MOD_ATT:N-N (expression,week)
MOD_ATT:N-N (expression,decrease)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD:ADV-N (after,week)
MOD_ATT:N-N (treatment,initial)